












Epithelial-mesenchymal transition, translocation of Ca
2+
 
signalling complexes and regulation of migration in 








Thesis submitted in accordance with the requirements of the University of Liverpool 






























Table of Contents 





Chapter 1: Introduction……………………………………………………12 
1.1 IP3R-mediated Ca
2+ responses…………………………………………................13 
1.1.1 Ca2+ signalling and ER……………………………………………………..............13 
1.1.2 Structure of IP3Rs…………………………………………………………..............14 
1.1.3 Regulation and gating of IP3Rs…………………………………………...............16 
1.1.4 Subcellular localisation of IP3Rs…………………………………………..............21 
1.2 Endoplasmic reticulum-Plasma membrane (ER-PM) junctions….………….27 
1.2.1 ER-PM junctions…………………………………………………………………….27 
1.2.2 Store operated Ca2+ entry (SOCE)………………………………………………..28 
1.3 Cell migration and its regulation by Ca2+ signalling…………………………...32 
1.3.1 Cell migration and the polarity of migrating cells………………………..............32 
1.3.2 Regulation of cell migration by Ca2+ signalling…………………………………...36 
1.4 Aims…………………………………………………………………………………….38 
Chapter 2: Materials and Methods………………………………………39 
2.1 Materials……………………………………………………………………………….40 
2.1.1 Reagents and equipment for pancreatic ductal adenocarcinoma cell line 
(PANC-1) culture and transfection……………………………………………………….40 
2.1.2 Chemicals…………………………………………………………………...............40 
2.1.3 Reagents and materials for Immunofluorescence and Immunoblotting……….41 
2.1.4 Equipment for super-resolution imaging, Boyden chamber migration and 
wound-healing/scratch migration assay…………………………………………………42 
2.2 Methods………………………………………………………………………………..43 




2.2.2 Constructs, cell transfection and siRNA knockdown…………………………….43 
2.2.3 Quantitative real-time PCR.………………………………………………………..49 
2.2.4 Immunoblotting………………………………………………………………………52 
2.2.5 Immunofluorescence and confocal microscopy imaging………………………..53 
2.2.6 Live-cell imaging, Ca2+ imaging and uncaging………………………….............55 
2.2.7 Boyden Chamber Migration assay………………………………………..............56 
2.2.8 Wound-healing/Scratch migration assay………………………………………….57 
2.2.9 Testing effects of Xestospongin-B and GSK-7975A on cell viability…………..58 
2.2.10 Super-resolution imaging………………………………………………………….58 
2.2.11 Image, data and statistical analyses……………………………………………..60 
Chapter 3: The expression and distribution of IP3Rs and ER-PM 
junctions in pancreatic ductal adenocarcinoma cells…...................62 
3.1 Epithelial phenotype and monolayer……………………………………………..63 
3.2 Expression of endogenous IP3Rs in PANC-1 cells…………………………….64 
3.3 IP3Rs expressed in PANC-1 cells are functional Ca
2+ release 
channels……………………………………………………………………………………70  
3.4 Distribution of IP3Rs in connected PANC-1 cells………………………………74 
3.5 IP3R1 localises to cell-cell contact sites in PANC-1 cell monolayer and 
clusters……………………………………………………………………………………..82 
3.6 Expression of endogenous STIM1 and Orai1 in PANC-1 cells………………87 
3.7 Localisation of IP3R1 and ER-PM junctions in connected PANC-1 
cells…………………………………………………………………………………………89 
3.8 Discussion…………………………………………………………………………….95 
Chapter 4: Redistribution of IP3Rs and ER-PM junctions in 
pancreatic ductal adenocarcinoma cells during epithelial-
mesenchymal transition…………………………………………………101 
4.1 Epithelial-mesenchymal transition………………………………………………102 
4.2 During EMT PANC-1 cells change cellular morphology…………………….104 
4.3 IP3Rs exhibit differential subcellular distribution in migrating PANC-1 
cells………………………………………………………………………………………..106 





4.5 Localisation of IP3R1 and ER-PM junctions in migrating PANC-1 
cells………………………………………………………………………………………..122 
4.6 Discussion…………………………………………………………………..............132 
Chapter 5: IP3Rs and ER-PM junctions regulate pancreatic ductal 
adenocarcinoma cell migration………………………………………...137 
5.1 Cell migration and its regulation by IP3Rs and SOCE……………………….138   
5.2 Inhibition of IP3-induced Ca
2+ release and store-operated Ca2+ entry (SOCE) 
suppresses PANC-1 cell migration…………………………………………………..139 
5.3 Cellular depletion of IP3Rs suppresses PANC-1 cell migration……………147 
5.4 Cellular depletion of STIM1 suppresses PANC-1 cell migration…………..154 
5.5 IP3R1 co-positions with actin- and phospholipid-rich regions at the leading 
edge of migrating PANC-1 cells………………………………………………………157 
5.6 STIM1 / ER-PM junctions localise close to focal adhesions in migrating 
PANC-1 cells………………………………………………………...............................160 
5.7 IP3R1 encompass focal adhesions and controls focal adhesion remodelling 
in migrating PANC-1 cells……………………………………………………………..163 
5.8 Discussion…………………………………………………………………..............175 
Chapter 6: Concluding Remarks……………………………………….183 
6.1 Keynote……………………………………………………………………………….184 














The high mortality of pancreatic cancer is predominantly caused by tumour metastasis. 
The formation of metastases is dependent on the co-ordinated processes of epithelial-
mesenchymal transition (EMT), cell migration and invasion. The importance of Ca
2+
 
signalling in the formation of metastasis in a number of cancer types has been 
documented. However, our understanding of the Ca
2+
 signalling components involved in 
the metastatic dissemination of pancreatic ductal adenocarcinoma (PDAC, specifically 
PANC-1) is limited. Inositol 1,4,5-trisphosphate receptors (IP3Rs) and store-operated 
Ca
2+
 entry (SOCE) channels are the important Ca
2+
 signalling mechanisms in this cell 
type. IP3Rs are Ca
2+
-releasing channels in the endoplasmic reticulum (ER). After Ca
2+
 
release via IP3Rs, restoring of ER Ca
2+ 
involves SOCE mediated by STIM1, which 
activates PM Ca
2+ 
channels Orai1 to permit Ca
2+ 
influx. This process of Ca
2+ 
influx takes 
place in unique structures – ER-PM junctions. The goal of the present study was to 
determine and characterise the fate of IP3Rs and STIM1-competent ER-PM junctions 
during EMT and the significance of these Ca
2+ 
signalling mechanisms for PANC-1 cell 
migration. 
In the present study, I demonstrated that during EMT, PANC-1 cells undergo a dramatic 
morphological change from apical-basal polarity to front-rear polarity. In cellular 
monolayers IP3Rs are juxtaposed to cell-cell contacts and closely co-positioned with 
markers of the tight and adherens junctions. When individual cells migrate away from 
their neighbours, IP3Rs and SOCE-competent ER-PM junctions underwent dramatic 
redistribution from cell-cell contacts to accumulate preferentially at the leading edge of 
PANC-1 cells, where they are in close apposition with the components of migratory 
apparatus (e.g. focal adhesions). I further demonstrated that focal adhesions were 
closely encompassed by IP3Rs, creating potholes in excitable medium in which Ca
2+
 
released through IP3Rs affects the remodelling and turnover of focal adhesions, which in 
turn is necessary for cell migration. Finally, I demonstrated that the migration of PANC-1 
cells was suppressed by inhibition of IP3Rs and SOCE, indicating that these 
mechanisms are functionally important for migration. 
Taken together, I successfully demonstrated that Ca
2+
 signalling complexes concentrate 
in the leading edge of migrating PANC-1 cells and regulate focal adhesion turnover in 
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Chapter 1: Introduction 
1.1 IP3R-mediated Ca
2+ responses 
1.1.1 Ca2+ signalling and ER 
Ca2+ is a remarkable, versatile and ubiquitous second messenger molecule that 
controls plethora of biological processes starting from when life begins at fertilisation, 
all the way through development, and eventually when life is terminated at death 
(Berridge et al., 1998). Ca2+ is able to mediate a vast number of cellular processes 
because of its enormous versatility as a second messenger, which is orchestrated 
through its complex spatial and temporal patterning (Berridge et al., 2000). Ca2+ 
fluxes from both internal and external reservoirs are utilised by cells to generate their 
Ca2+ signals (Berridge et al., 2000). External reservoirs are situated in the 
extracellular environment outside cells, whilst the internal reservoirs are held within 
the intracellular organelles primarily the endoplasmic reticulum (ER) (Ehrlich & 
Watras, 1988; Berridge et al., 1998). 
The ER is an intracellular organelle that was first described using electron 
microscopy by Porter and colleagues (Porter et al., 1945). The ER is characterised 
by a tubular and a membranous network consisting of three morphologically distinct 
compartments: the nuclear envelope (NE), the rough ER and the smooth ER 
(Baumann & Walz, 2001; Voeltz et al., 2002). The ER is a heterogeneous 
compartment with many different functions within its different sub-compartments 
(Meldolesi & Pozzan, 1998). The ER functions as sites for lipid synthesis, protein 
synthesis and sorting as well as forming the major intracellular Ca2+ reservoir in most 
cells (Ashby & Tepikin, 2001; Baumann & Walz, 2001; Berridge, 2002). The 




by the increased density of Ca2+ uptake pumps, luminal Ca2+ sequestering proteins, 
and Ca2+ release channels (primarily the inositol 1,4,5-trisphosphate receptor (IP3Rs) 
and ryanodine receptors (RyRs)) (Berridge et al., 2000; Petersen et al., 2001). The 
ER lumen holds a substantial amount of [Ca2+]ER of ~400 μM compared to the resting 
level of cytosolic [Ca2+]C of ~50-100 nM, and maintaining the steep gradient between 
the two cellular compartments is essential for efficient Ca2+ response signals after 
receptor stimulation (Foskett et al., 2007; Carrasco & Meyer, 2011). Briefly, 
stimulation of cell surface receptors for example G-protein coupled receptors 
(GPCRs) and receptor tyrosine kinases (RTKs) lead to the activation of multiple 
isoforms of phospholipase C (PLC) enzyme, which in turn catalyses the hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to generate inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG). IP3 then subsequently binds IP3Rs in 
the ER membrane to mediate intracellular Ca2+ release (Berridge et al., 1998; 
Berridge et al., 2000; Foskett et al., 2007; Carrasco & Meyer, 2011). IP3R is an 
important platform for intracellular Ca2+ signalling, which is essential for many 
cellular processes including gene expression, cell proliferation, contraction, 
secretion, motility and cell death (Patterson et al., 2004; Vermassen et al., 2004; 
Foskett et al., 2007). 
1.1.2 Structure of IP3Rs 
IP3Rs are intracellular Ca
2+ release channels localised predominantly in the ER 
membrane (Foskett et al., 2007). There are three mammalian isoforms of IP3Rs 
(IP3R1, IP3R2 and IP3R3), which are encoded by three distinct genes (Furuichi et al., 
1994; Taylor et al., 1999; Patterson et al., 2004). Each isoform is a six 
transmembrane protein with both N- and C- termini projecting into the cytoplasm 




sequence homology (Furuichi et al., 1994; Taylor et al., 1999; Foskett et al., 2007). 
Functional IP3Rs are tetrameric complexes that can be present as homo- and/or 
heterotetramers and with their subunits splice variants contributing to receptor 
diversity (Joseph et al., 1995; Monkawa et al., 1995; Taylor et al., 1999; Foskett et 
al., 2007). IP3R isoforms have a primary sequence of ~2700-2800 amino acids, and 
they share a similar general structure consisting of N-terminal IP3 binding core 
region, a large central modulatory and transducing region (also known as the 
coupling domain), and a C-terminal channel-forming region (Mignery & Sudhof, 
1990; Miyawaki et al., 1991; Bosanac et al., 2004; Foskett et al., 2007; Taylor & 
Tovey, 2010). 
The N-terminal region of IP3Rs is about 600 amino acids in length and is composed 
of two key domains, the suppressor domain (SD) which is adjacent to the IP3-binding 
core (IBC) (Bosanac et al., 2004). IP3Rs without the SD region bind IP3 but fails to 
open the channel pore (Uchida et al., 2003; Szlufcik et al., 2006). It was also s 
bhown that IP3R1 lacking the SD region failed to induce clustering following cell 
surface receptor-stimulated IP3 production (Tateishi et al., 2005). Therefore, It has 
been suggested that the SD is an essential link between IP3 binding to the IBC and 
the follow-up conformational changes that lead to pore opening and receptor 
clustering (Tateishi et al., 2005; Rossi et al., 2009; Taylor & Tovey, 2010). The SD 
region has also been reported to house interaction sites for proteins that regulate 
IP3R activity, and these include calmodulin (Sienaert et al., 2002), Homer (Tu et al., 
1998), and phosphorylation sites for several kinases (Vanderheyden et al., 2009). 
However, the precise location of the SD region within the 3D structure of IP3Rs is yet 




The coupling domain is a large region of ~1600-1700 amino acids in length and it is 
located between the N-terminal IBC and the C-terminal channel-forming regions 
(Bosanac et al., 2004; Foskett et al., 2007). This region is the least conserved region 
amongst the IP3R isoforms (Tu et al., 2005). This region contains different 
consensus sequences for numerous target proteins that interact with and modulate 
the activity of IP3Rs. For example, phosphorylation sites for protein kinase A/G 
(PKA/PKG), extracellular-signal regulated kinase (ERK) and cyclin-dependent kinase 
1 (CDK1) (Vanderheyden et al., 2009), in addition to two glycine-rich regions that are 
putative ATP-binding sites (Furuichi et al., 1989; Mignery & Sudhof, 1990; Tu et al., 
2005; Vanderheyden et al., 2009) are all found in the coupling domain of IP3R1. This 
region also contains additional regulatory interaction sites for AKAP9, Bcl-2 and 
calmodulin (only in IP3R1 and IP3R2) (Yamada et al., 1995; Michikawa et al., 1999). 
The C-terminal Ca2+ release channel-forming region is composed of six 
transmembrane domain (TMD), and binding sites for a number of other regulatory 
and adaptor proteins such as phosphatase PP1A and protein 4.1N, respectively 
(Vermassen et al., 2004). Similar to ryanodine receptor channel pore, the final pairs 
of TMD5-6 and the luminal loop that links them in each of the tetrameric subunits 
form the pore of the IP3Rs (Ramos-Franco et al., 1999). IP3Rs have astonishingly 
large conductance of ~50 pS (Williams et al., 2001; Foskett et al., 2007). 
1.1.3 Regulation and gating of IP3Rs 
The regulation of IP3R activity has been postulated to be an important factor for the 
spatial and temporal coding of Ca2+ signals that control numerous cellular processes. 
Multiple intracellular mechanisms exist that are known to regulate the activity of 




free Ca2+, free ATP), post-translational modifications, protein-protein interactions, 
receptor clustering, tetrametric compositions (homo- and hetero-tetramer) and 
differential localisation (Bezprozvanny et al., 1991; Bezprozvanny & Ehrlich, 1993; 
Wojcikiewicz, 1995; Miyakawa et al., 1999; Berridge et al., 2000; Pieper et al., 2001; 
Patterson et al., 2004; Vermassen et al., 2004; Tateishi et al., 2005; Tu et al., 2005; 
Foskett et al., 2007; Taylor & Tovey, 2010; Decuypere et al., 2011).  
The primary activator of IP3R-mediated Ca
2+ release is a soluble second messenger 
molecule called IP3 (Berridge, 1983; Ehrlich & Watras, 1988). IP3 is synthesized from 
the hydrolysis of (PI(4,5)P2) by the action of PLC upon cell surface receptor 
activation (for example, GPCRs and/or RTKs) (Berridge, 1983, 1993; Furuichi & 
Mikoshiba, 1995; Foskett et al., 2007). Mutational analysis provided further support 
for the current consensus that IP3 binds to the IP3-binding core (IBC) at the N-
terminal domain of the receptor to stimulate Ca2+ release via the channel-forming 
region of the receptor tetramer (Furuichi & Mikoshiba, 1995; Yoshikawa et al., 1996; 
Taylor & Tovey, 2010). IP3R isoforms differ in their affinity for IP3 – 
IP3R2>IP3R1>IP3R3 (Miyakawa et al., 1999; Tu et al., 2005). SD within the N-
terminal region of IP3Rs has been suggested to be an important determinant of the 
differing affinities exhibited by the IP3R isoforms for IP3 (IP3R2>IP3R1>IP3R3) (Iwai et 
al., 2007). In addition to IP3 being the primary activator ligand, cytosolic free Ca
2+ 
has also been shown to regulate the activity of IP3-induced Ca
2+ release (IICR) as a 
co-agonist (Bezprozvanny et al., 1991; Finch et al., 1991; Miyakawa et al., 1999; 
Foskett et al., 2007; Taylor & Tovey, 2010). 
Cytosolic free Ca2+ has been shown to have a biphasic effect on IICR (the so-called 
bell-shaped Ca2+ dependence curve) (Bezprozvanny et al., 1991; Finch et al., 1991; 




with maximum channel activity observed at ~200-300 nM, whereas higher 
concentrations (>300-500 nM) exhibited inhibitory effect on IICR in guinea pig 
smooth muscles (Iino, 1990), canine cerebellum (Bezprozvanny et al., 1991), mouse 
cerebellum (Michikawa et al., 1999), rat brain synaptosomes (Finch et al., 1991), and 
B-cells (Miyakawa et al., 1999). Increased [Ca2+]C at ≥300 nM also reversibly 
inhibited IP3 binding to IP3Rs (Supattapone et al., 1988; Thrower et al., 1998). 
Cytosolic free Ca2+ has both potentiating and inhibitory effects on IICR and both 
effects are universally accepted phenomena. There is a universal understanding that 
the stimulatory or potentiating effect of cytosolic Ca2+ on IICR is a result of Ca2+ 
directly interacting with IP3R after Ca
2+ release through the receptor (Michikawa et 
al., 1999; Foskett et al., 2007; Taylor & Tovey, 2010). However, how cytosolic Ca2+ 
confers its inhibitory effect on IICR is still a subject of intense debate. One side of the 
debate argues that Ca2+ inhibition is a result of free Ca2+ binding directly to the 
receptor (Marshall & Taylor, 1994; Thrower et al., 1998), while the other side states 
that Ca2+ inhibition is likely to be mediated by an accessory Ca2+-binding protein(s) 
(Supattapone et al., 1988; Michikawa et al., 1999). In support of Ca2+ acting directly 
on IP3R to exercise its inhibitory effect, the proposed model was that there are two 
distinct Ca2+-binding sites with differing affinities for Ca2+ within the IP3R that are 
thought to mediate both stimulatory and inhibitory effects of cytosolic Ca2+ (Marshall 
& Taylor, 1994; Striggow & Ehrlich, 1996). Another proposed model was that there is 
a single Ca2+-binding site that switches from being inhibitory in the absence of IP3 to 
stimulatory in the presence of IP3 (Mak et al., 2003). Finally Ca
2+ inhibition could be 
mediated by an accessory Ca2+-binding protein. Supporting evidence in favour of the 
inhibitory effect of cytosolic Ca2+ exerted via an accessory protein(s) on IICR cannot 




dependence of IICR as a function of cytosolic Ca2+, in other words bell-shaped 
dependence on Ca2+ is restricted to microsomal vesicles and crude extract 
preparations (Supattapone et al., 1988; Bezprozvanny et al., 1991; Finch et al., 
1991; Michikawa et al., 1999). In support of these observations, in the presence of 
high free Ca2+ level, even as high as 1.5 mM, IP3 binding to purified IP3R1 was 
unaffected but inhibition was restored in the presence of detergent-solubilized 
cerebellar membranes (Supattapone et al., 1988). Purified IP3R1-mediated Ca
2+ 
release activity could be stimulated, but not inhibited by high cytosolic Ca2+ 
(Michikawa et al., 1999). Also partially purified IP3R2 isolated from ventricular 
cardiac myocytes failed to exhibit the bell-shaped dependence of cytosolic Ca2+ 
(Ramos-Franco et al., 1998). These observations triggered the search for a potential 
accessory/auxiliary protein(s) that could be responsible for mediating this inhibitory 
effect.  
One potential candidate for this role is calmodulin (CaM), a well-characterised Ca2+-
binding protein (Gnegy, 1993). Purified mouse cerebellar IP3R1 was shown to bind 
CaM in a Ca2+-dependent manner (Maeda et al., 1991). Yamada et al. (1995) also 
demonstrated that CaM binds IP3R1 and IP3R2 in a Ca
2+-dependent manner, 
whereas IP3R3 does not bind CaM even in the presence of 1.5 mM Ca
2+. The 
binding sites of CaM have been mapped to the SD region within the N-terminal 
domain of IP3R1 (Sienaert et al., 2002) and within residues 1564-1585 and 1558-
1596 in the coupling domain of IP3R1 and IP3R2, respectively (Yamada et al., 1995). 
Michikawa et al. (1999) provided exquisite evidence by demonstrating that the 
addition of CaM restored Ca2+ inhibition to purified IP3R1, which in the absence of 
CaM was resistant to inhibition at high Ca2+ concentration (~200 M). They also 





was reversed in the presence of CaM antagonist W-7 (Hidaka et al., 1981) in a dose-
dependent manner (Michikawa et al., 1999). Missiaen and colleages also showed 
that exogenous CaM inhibits IICR in permealised A7r5 cells (Missiaen et al., 1999). It 
was also shown in DT40 cells, that IICR via IP3R3 failed to exhibit the biphasic Ca
2+ 
dependence (Miyakawa et al., 1999), perhaps because IP3R3 lacks a CaM binding 
site (Yamada et al., 1995). In addition, IP3R3 in RIN-5F cells is activated 
monotonically with increased cytosolic Ca2+ up to 100 M (Hagar et al., 1998). 
Another cofactor involved in the regulation of IP3R activity is cytosolic ATP (Ehrlich & 
Watras, 1988; Iino, 1991; Maeda et al., 1991; Bezprozvanny & Ehrlich, 1993; 
Miyakawa et al., 1999; Tu et al., 2005). It is noteworthy that ATP alone is not 
sufficient to stimulate IP3R channel opening but it elicits its potentiating effect in the 
presence of IP3 (Bezprozvanny et al., 1991; Iino, 1991; Bezprozvanny & Ehrlich, 
1993; Tu et al., 2005). It was demonstrated that IP3R activity is enhanced or 
potentiated by cytosolic ATP in a hydrolysis-independent manner in smooth muscle 
(Iino, 1991) and cerebellar preparation (Bezprozvanny & Ehrlich, 1993). Supporting 
evidence comes from using non-hydrolysable ATP analogues in the presence of IP3, 
which produced similar potentiating effect (Ehrlich & Watras, 1988; Bezprozvanny & 
Ehrlich, 1993). Isoforms of IP3R differ in their ATP dependence of Ca
2+ release with 
IP3R1 channel gating been the most sensitive to ATP and IP3R3 channel gating was 
less sensitive, whereas IP3R2 channel gating was insensitive to ATP (Miyakawa et 
al., 1999; Tu et al., 2005). Tu et al. (2005) hypothesised that under optimal 
conditions (i.e. in the presence of maximal IP3) required for channel activity IP3R2 
was insensitive to ATP. This was later demonstrated to be correct. IP3R2 channel 
gating was indeed sensitive to ATP but only in the presence of sub-saturating [IP3], 




sensitive of all isoforms under this condition (Betzenhauser et al., 2008; 
Betzenhauser et al., 2009; Wagner & Yule, 2012; Vervloessem et al., 2014). 
Post-translational modifications i.e. phosphorylation/dephosphorylation of IP3Rs 
have also been linked to the fine-tuning of Ca2+ release activity and efficient Ca2+ 
signals, which in turn are essential for numerous cellular processes ranging from 
oocyte maturation to cell death (Pieper et al., 2001; Vanderheyden et al., 2009). 
From the primary sequence of IP3R isoforms, there are multiple phosphorylation 
consensus sites and numerous docking sites for protein kinases and phosphatases 
such as protein kinase A (PKA) and protein phosphatase (PP1), respectively. 
Currently, at least 12 different protein kinases are believed to directly phosphorylate 
the IP3Rs. Adding to the complexity of the modulation of IP3R activity by regulatory 
proteins such as IRBIT and Bcl-2 that associate with IP3Rs are themselves regulated 
by phosphorylation and/or dephosphorylation (Vanderheyden et al., 2009). 
Collectively, numerous intracellular factors co-operatively contribute to the regulation 
of IP3R gating and IICR. 
1.1.4 Subcellular localisation of IP3Rs 
IP3Rs are intracellular Ca
2+ release channels primarily located in the membranes of 
the ER (Vermassen et al., 2004). The three isoforms of IP3Rs share common 
similarities in structure (Mignery & Sudhof, 1990; Miyawaki et al., 1991) but they 
differ in many respects with regards to their subcellular localisation and cellular 
abundance, regulation by small intracellular molecules (IP3, free Ca
2+ and ATP), 
post-translational modifications (i.e. phosphorylation), degradation by proteases 
during prolonged agonist stimulation and protein-protein interactions (Wojcikiewicz, 




et al., 2011; Pantazaka & Taylor, 2011). Vermassen et al. (2004) postulated that the 
exact subcellular localisation of IP3Rs is an important determinant for the correct 
initiation, propagation of Ca2+ signals and the physiological consequences of IP3-
induced Ca2+ release. Unregulated Ca2+ signalling is implicated in a vast number of 
pathological conditions including cancer, cardiovascular and neurodegenerative 
diseases (Berridge et al., 2000; Decuypere et al., 2011; Vervloessem et al., 2014). It 
is therefore essential to appreciate the significance of the expression and distribution 
of IP3R Ca
2+ release channels in the context of many physiological functions. In most 
cell and tissue types, isoforms of IP3R are differentially expressed (Wojcikiewicz, 
1995) and with the availability of good isoform-specific antibodies and the use of 
fluorescently labelled IP3Rs, the subcellular localisation and distribution of IP3R 
isoforms have been determined and shown not to be uniformly distributed within the 
ER (Vermassen et al., 2004). It is a general consensus among researchers in the 
field that the relative expression levels and the subcellular localisation of IP3Rs 
varies widely, for example, within a particular cell type (COS cells) and in different 
cell types depending on the isoform expressed (Wojcikiewicz, 1995; Vermassen et 
al., 2004; Pantazaka & Taylor, 2011). 
In the brain, IP3R1 is highly expressed (~ 96% of total IP3Rs) and IP3R2 is expressed 
in trace amount (~ 4% of total IP3Rs) with no apparent detection of IP3R3 expression 
(Wojcikiewicz, 1995). However, some IP3R3 was detected in neuronal terminals 
(Sharp et al., 1999). IP3R1, the first of the three isoforms to be identified was purified 
and cloned from rat/mouse cerebellum because of its high abundance in this tissue 
(Supattapone et al., 1988; Furuichi et al., 1989). It was later confirmed and currently 
accepted that neuronal cells in the central nervous system mainly express IP3R1 




there are five distinct neuronal cell types, one of which is the Purkinje cell, which 
plays a key role in information processing expresses high density of IP3R1 (Furuichi 
et al., 1989; Wojcikiewicz, 1995). Using immunohistochemical technique, the 
distribution of IP3R1 has been shown to localise throughout the cell including the 
axon, dendrites and cell bodies (Maeda et al., 1989). This uniformly observed 
distribution could perhaps account for the total IP3R1 present in the cerebellar cells 
without distinguishing between the differential subcellular localisation of post-
translationally modified IP3R1 and unmodified IP3R1. More than a decade later, 
Pieper et al. (2001) showed that in cerebellar Purkinje neurons of the brain, protein 
kinase A (PKA)-phosphorylated IP3R1 was selectively enriched in dendrites while the 
unphosphorylated version of the receptor was most prominent in cell bodies. Besides 
the ER being uniformly distributed within the cell (Finch & Augustine, 1998; Takechi 
et al., 1998), IP3-induced Ca
2+ release (IICR) evoked by synaptic stimuli is 
predominantly restricted to the spines of Purkinje cells (Fukatsu et al., 2010) and is 
important for the induction of long-term depression (LTD) (Inoue et al., 1998). This 
perhaps suggest that post-translational modification i.e. phosphorylation could play a 
role in the differential activity and functional properties of IP3R1 in the brain.  
Ca2+ signalling and the differential localisation of IP3R isoforms have also been 
studied in epithelial cells because of their polarised nature and vectorial transport 
functions, which requires specialised signalling microdomains (Vermassen et al., 
2004). Early work by Wojcikiewicz (1995) in AR4-2J rat pancreatoma cells and in rat 
pancreas showed that these cells expressed all three isoforms but their relative 
abundance varied widely. In rat pancreas tissue, IP3R2 and IP3R3 were mainly 
expressed with relative abundance of 53% and 44%, respectively, while IP3R1 




predominantly expressed with a relative abundance of 86% and to a much lesser 
extent followed by that of IP3R1 and IP3R3 (Wojcikiewicz, 1995). In COS cells (COS-
1) IP3R isoforms are expressed in the relative abundance order of IP3R3 
(62%)>IP3R2 (37%)>IP3R1 (1%) (Wojcikiewicz, 1995). With the use of isoform-
specific antibodies, it has been shown that all three isoforms localise to the apical 
part of pancreatic acinar cells (Lee et al., 1997; Yule et al., 1997; Lur et al., 2009; Lur 
et al., 2011). Differential distribution of IP3Rs has also been reported in some 
epithelial cells expressing at least two isoforms. For example, in non-pigmented 
epithelial cells, IP3R1 was localised at the basal pole whereas IP3R3 was 
concentrated at the apical part of the cell (Hirata et al., 1999). In cholangiocytes, 
IP3R1 and IP3R2 were shown to be uniformly distributed throughout the cytoplasm 
whereas IP3R3 was mostly localised to the apical part (Hirata et al., 2002a). Also in 
hepatocytes, the distribution of apical-localised IP3R2 was different from IP3R1, 
which was uniformly distributed (Hirata et al., 2002b). In addition, it’s become 
apparent that the subcellular localisation of IP3Rs is dynamic and most likely 
depends on the physiological status of a cell (Vermassen et al., 2004). For example, 
the maturation/oogenesis of oocytes is accompanied by the re-localisation of the 
predominant isoform IP3R1 from a uniformly cytoplasmic distribution to a more 
polarised localisation in the cortical regions (Kume et al., 1997). During the course of 
Madin-Darby canine kidney (MDCK) cell polarity development i.e. transition from 
subconfluence phase to a polarised phase, IP3Rs underwent an apparent change in 
their subcellular localisation from a distribution throughout the cytoplasm and in the 
perinuclear region (like other ER markers) to a concentrated localisation near the 
lateral membranes and in close vicinity of the tight junctions (Colosetti et al., 2003; 




In smooth muscle cells, the subcellular distribution of IP3R isoforms differ in that 
IP3R1 was primarily distributed throughout the cytoplasm, IP3R3 was mainly found in 
the perinuclear region whereas a heterogeneous distribution of IP3R2 was observed 
in different cellular areas including near the plasma membrane (called 
plasmerosome – close associations between plasma membrane and the junctional 
components of ER) (Blaustein & Golovina, 2001) and in the perinuclear region 
(Tasker et al., 2000). IP3R1 expression is relatively high in smooth muscle cells but 
to lesser degree compared to that in the cerebellum. Its subcellular distribution varies 
widely depending on the muscle cell type (Vermassen et al., 2004). IP3R1 was found 
in the peripheral smooth ER in vas deferens, an example of phasic smooth muscle 
(Nixon et al., 1994), whereas in tonic smooth muscle (aorta) IP3R1 was centrally 
localised because for the most part, its ER is centrally located (Nixon et al., 1994).  
Much lesser IP3R density is expressed in skeletal and cardiac muscles, where IP3R2 
is the predominant isoform (Vermassen et al., 2004). In addition, the redistribution of 
IP3R1 was observed in vascular smooth muscle cell line A7r5 from a perinuclear-
localised region to a more cytoplasmic localisation upon vasopressin stimulation 
(Vermassen et al., 2003). 
The importance of the subcellular localisation and redistribution of IP3Rs in shaping 
the physiological consequences of IP3-induced Ca
2+ release signals are thought to 
be essential for many physiological functions and is increasingly becoming more 
appreciated. However, the molecular determinants and/or mechanisms underlying 
the redistribution and discrete subcellular localisation are currently not well 
elucidated. Moreover, in recent times, some advances have been made to elucidate 
the potential participating molecular determinants. Cytoskeletal proteins (Rossier et 




proteins (Dingli et al., 2012), phospholipids – PI(4,5,)P2 (Lupu et al., 1998), post-
translational modifications (i.e. phosphorylation) (Pieper et al., 2001; Vanderheyden 
et al., 2009), and microtubule dynamics and/or diffusion (Aihara et al., 2001; 
Vermassen et al., 2003) have all been implicated in the control of IP3Rs localisation 
(Vermassen et al., 2004). Actin cytoskeleton has been reported to play a crucial role 
in the localisation and positioning of IP3Rs and IP3-sensitive Ca
2+ stores in close 
vicinity of the plasma membrane (Rossier et al., 1991; Delmas et al., 2002; 
Johenning & Ehrlich, 2002). The ER is a relatively dynamic structure and this is 
thought to be dependent on the status of the cytoskeleton (Aihara et al., 2001; 
Berridge, 2002; Vermassen et al., 2004). Since the primary location of IP3Rs is the 
ER membrane, one would perhaps suggest that the subcellular localisation of IP3Rs 
should be dependent on the ER morphology within a cell. In addition, a direct 
interaction between IP3Rs and actin has been demonstrated through co-
immunoprecipitation experiment (Sugiyama et al., 2000). In hippocampal neurons, 
actin-dependent regulation of IP3R1 lateral diffusion is mediated by a linker protein 
4.1N, which binds to actin-spectrin filaments and to the IP3R1 C-terminal (Fukatsu et 
al., 2004). In Purkinje cells, Fukatsu et al. (2010) showed that actin filaments play a 
part in the regulation of IP3R1 diffusion in the spines upon glutamate receptor 
activation; however, adaptor protein 4.1N is unlikely to be involved. Recently, in 
polarised MDCK cells, the coupling domain of IP3Rs has been identified to be 
essential for targeting the receptor to the tight junction vicinity via an interaction with 
adaptor protein K-Ras-induced actin-binding protein (KRAP)-vimentin/keratin 
complexes (Dingli et al., 2012). Collectively, these reported observations suggest 
that different molecular determinants are likely to be involved in the subcellular 




1.2 Endoplasmic reticulum-Plasma membrane (ER-PM) junctions 
1.2.1 ER-PM junctions 
ER-PM junctions are specialised regions of close contact between the two 
organelles usually with an inter-membrane space of 7 to 25 nm (Wu et al., 2006; 
Varnai et al., 2007; Lur et al., 2009; Orci et al., 2009; Carrasco & Meyer, 2011; 
Chang et al., 2013; Wu et al., 2014). More than half a century ago, the existence of 
ER-PM junctions was observed in electrically excitable cells – first in striated 
muscles (Porter & Palade, 1957) and then later in neurons (Rosenbluth, 1962) using 
electron microscopy (EM) studies. These specialised contacts are formed between 
the ribosome-free terminals of the ER and the PM (Lur et al., 2009; Orci et al., 2009). 
Other key remarkable characteristics of the ER-PM junctions is that these 
specialised regions/platforms are: 1) a restricted protein-rich cytosolic microdomain, 
2) the identity of both membranes are conserved due to the lack of any observable 
evidence of fusion between the two membranes (i.e. inter-membrane space of >0 
and ≤25 nm) and 3) can be both stable and dynamic (Wu et al., 2006; Lur et al., 
2009; Carrasco & Meyer, 2011; Dingsdale et al., 2013). Therefore, this specialised 
platform must house complexes important for bridging the two membranes. A 
number of proteins including ER luminal proteins, cytosolic proteins and integral ER 
membrane proteins especially junctate (Treves et al., 2004) and junctophilin 
(Takeshima et al., 2000) have been reported to have a role in ER-PM junction bridge 
formation (Carrasco & Meyer, 2011). Recently, a number of elegant studies 
performed in yeast (Manford et al., 2012) and mammalian cells (Chang et al., 2013) 
have identified additional key proteins involved in tethering and maintaining the 
integrity of ER-PM junctions. In yeast cells, in order of importance – Scs2 and Scs22 




mammalian TMEM16 ion channels) and the tricalbins (Tcb1/2/3, orthologs of the 
extended synaptotagmins) were all identified to be essential for tethering ER-PM 
junctions using quantitative proteomic approach (Manford et al., 2012). In 
mammalian cells (HeLa), using genetically encoded ER-PM marker membrane-
attached peripheral ER (MAPPER), it was shown that cell surface receptor 
stimulation-mediated elevation of cytosolic Ca2+ enhanced the ER-PM connection via 
the recruitment and translocation of extended synaptotagmin (E-Syt1) (Chang et al., 
2013). 
ER-PM junctions provide a platform for direct signal transduction between the ER 
and the PM in eukaryotes (Carrasco & Meyer, 2011). Currently, this platform has 
been demonstrated to serve as signalling hubs for Ca2+ signalling (Wu et al., 2006; 
Varnai et al., 2007; Lur et al., 2009; Chang et al., 2013; Wu et al., 2014), 
phosphatidylinositol transfer, turnover and signalling (Carrasco & Meyer, 2011; 
Manford et al., 2012; Chang et al., 2013) and cAMP signalling (Lefkimmiatis et al., 
2009; Willoughby et al., 2012). ER-PM junctions have been unequivocally shown to 
be important in bidirectional Ca2+ signalling i.e. in striated muscle excitation-
contraction coupling “outside-in” Ca2+ signalling, and store operated Ca2+ entry-
mediated “inside-out” Ca2+ signalling predominantly in non-excitable cells (Carrasco 
& Meyer, 2011). From here on in, the present study focuses on the roles of ER-PM 
junctions in store operated Ca2+ entry-mediated “inside-out” Ca2+ signalling. 
1.2.2 Store operated Ca2+ entry (SOCE) 
The “inside-out” Ca2+ signalling transduction pathway begins with the classic PM-
localised G-protein coupled receptors (GPCRs) and/or receptor tyrosine kinases 




hydrolysis of phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) to yield inositol 1,4,5-
trisphosphate (IP3) and diacylglycerol (DAG). IP3 binds to IP3Rs in the ER to mediate 
Ca2+ release (Berridge et al., 2000; Carrasco & Meyer, 2011). Following ER Ca2+ 
store emptying through IP3R Ca
2+-release channels in the ER, restoring of the ER 
Ca2+ concentration ([Ca2+]ER) involves Ca
2+ influx across the PM through store 
operated Ca2+ entry (SOCE) process (Putney, 1986; Berridge et al., 1998; Berridge 
et al., 2000; Putney, 2005; Carrasco & Meyer, 2011). This process of Ca2+ 
replenishment is particularly prominent in non-excitable cells (Berridge et al., 1998; 
Schindl et al., 2009). 
Intracellular Ca2+ store depletion triggers Ca2+ influx through SOCE mechanism, 
which is mediated by the dynamic interplay and coupling of ER Ca2+ sensor stromal 
interaction molecule (STIM) protein and PM Ca2+ release-activated Ca2+ (CRAC) 
channels Orai, which were both discovered by genome-wide RNA interference 
screens (Liou et al., 2005; Roos et al., 2005; Zhang et al., 2005; Feske et al., 2006; 
Vig et al., 2006; Zhang et al., 2006). STIM proteins are predominantly ER resident 
proteins that contain a single-pass transmembrane domain with an N terminal 
containing dual EF-hand Ca2+-binding motif that faces into the ER lumen (which 
senses ER luminal Ca2+ content) and a C terminus facing into the cytosol. Two 
structurally similar isoforms of STIM – STIM1 and STIM2 are expressed in 
vertebrates, albeit both isoforms only differ structurally at the extreme N and C 
termini (Liou et al., 2005; Deng et al., 2009). An additional population of STIM1 was 
reported to also localise in the PM (Zhang et al., 2005). Three closely related 
isoforms of Orai proteins have been identified, namely Orai1, Orai2 and Orai3 
(Feske et al., 2006; Vig et al., 2006). Orai is characterised by four transmembrane 




pore-forming subunit of the plasma membrane-localised CRAC channel (Feske et 
al., 2006). In its functional Ca2+ current conducting state, it exists as a tetramer 
(Deng et al., 2009; Muik et al., 2012). At resting state or before cell surface receptor-
stimulated IP3R-mediated ER Ca
2+ store depletion, STIM1 exist as monomers and is 
normally distributed uniformly within the ER membrane in a reticular manner as 
observed using confocal microscopy (Liou et al., 2005; Liou et al., 2007). Upon ER 
Ca2+ store depletion, Ca2+ dissociates from STIM1 EF hand motif, enabling STIM1 to 
undergo profound oligomerisation and redistribution into discrete junctional ER sub-
regions closely juxtaposed with the plasma membrane, a region called the ER-PM 
junctions. At these junctions STIM1 molecules aggregate, interact with and activate 
PM-localised Orai1 channels to induce Ca2+ entry (Liou et al., 2007; Deng et al., 
2009). The coupling of STIM1 oligomers to tetrameric pore-forming Orai1 channels 
has been shown to involve the interaction between the Orai coupling site located 
within the cytoplasmic domain of STIM1 and the C terminus of Orai1 (Muik et al., 
2008; Deng et al., 2009; Park et al., 2009; Muik et al., 2012). Meanwhile, the N-
terminus of Orai1 is essential for Orai1 channel gating and current activation (Feske 
et al., 2006; Muik et al., 2008; Park et al., 2009). In addition, Lewis and colleague 
postulated that the binding of 8 STIM1s to each tetrametric channel is required for 
peak CRAC channel activity by showing that the stoichiometric requirements for 
peak Ca2+ influx current was observed at a ratio of ~2 STIM1:Orai1 (Hoover & Lewis, 
2011). 
These ER-PM junctions are normally visualised as punctate structures using 
confocal microscopy (Liou et al., 2007; Varnai et al., 2007; Carrasco & Meyer, 2011; 
Chang et al., 2013; Dingsdale et al., 2013). Multiple molecular approaches have 




and following ER-Ca2+ store depletion, respectively. These include: fluorescent/HRP-
tagged STIM1 (Liou et al., 2005; Wu et al., 2006; Varnai et al., 2007), rapamycin-
inducible membrane linker technique (see Figure 2.1) (Varnai et al., 2007), and the 
recently developed, elegantly designed and non-invasive membrane-attached 

















1.3 Cell migration and its regulation by Ca2+ signalling 
1.3.1 Cell migration and the polarity of migrating cells 
Cell migration is a highly co-ordinated cellular behaviour integral to numerous 
physiological processes including embryogenesis, organ development, immune 
surveillance, wound healing and tissue regeneration after damage (Valeyev et al., 
2006; Ridley, 2011; Roussos et al., 2011; Lamouille et al., 2014). To date, it has 
been documented that most cell types undergo two distinct modes of migration: 
single cell migration and collective/cohort migration (Roussos et al., 2011). These 
modes of cell migration also play critical roles in the development and progression of 
various pathological conditions including cancer and inflammatory diseases 
(Hanahan & Weinberg, 2000; Friedl & Gilmour, 2009; Hanahan & Weinberg, 2011; 
Roussos et al., 2011). Cells can undergo both random and directional migration 
(Roussos et al., 2011; Burdyga et al., 2013). Cell migration in a directed fashion 
involves the co-ordination and sequential events of chemosensing, polarisation and 
locomotion (Iijima et al., 2002; Iglesias & Devreotes, 2008). Cell migration is thought 
to be most efficient when cells move in a directed fashion (Hanahan & Weinberg, 
2011; Roussos et al., 2011) in response to soluble extracellular cues (chemotaxis) 
(Yang et al., 2009; Burdyga et al., 2013), mechanical cues (mechanotaxis/durotaxis) 
(Provenzano et al., 2010; Roussos et al., 2011) and substrate-bound cues 
(haptotaxis) (Roussos et al., 2011). Directed cell migration in addition to cell 
adhesion and invasion are critical processes essential for the formation of metastasis 
and the development of chemotherapy-resistance phenotype of numerous 
cancer/tumour types including pancreatic ductal adenocarcinoma (PDAC) (Hanahan 




al., 2011; Chang et al., 2012; Siegel et al., 2013; Lamouille et al., 2014). PDAC is the 
4th leading cause of cancer-related mortalities worldwide (Siegel et al., 2011) and it is 
characterised by disseminated metastasis at diagnosis and poor prognosis with 
median survival period of less than 12 months (Siegel et al., 2013). 
Cells move forward by net protrusion/extension of their plasma membrane at the 
front leading edge, which is closely accompanied by the movement of the cell body 
(Ridley et al., 2003; Tsai & Meyer, 2012). Extension of the membrane at the leading 
edge requires the co-ordinated actions of structural components of specialised 
network of actin modules such as lamellipodia, filopodia and lamella (Burnette et al., 
2011; Ridley, 2011). Filopodia are actin-rich components involved in exploring the 
cell’s environment (Ridley, 2011). They are characterised by long, thin protrusions 
that extend from the plasma membrane which are composed of unbranched and 
parallel actin filaments/filamentous actin (F-actin) (Ridley et al., 2003; Mejillano et al., 
2004; Ridley, 2011). A number of regulatory proteins including Fascin and formins 
(primarily the mDia proteins) have been shown to localise to filopodia where they 
contribute to actin polymerisation and bundling in filopodia and filopodium stability 
(Campellone & Welch, 2010; Machesky & Li, 2010; Mellor, 2010; Ridley, 2011). 
Filopodia are thought to emerge, in part from the lamellipodial F-actin network 
(Ridley, 2011). Lamellipodia was first described to consist predominantly of F-actin 
and devoid of microtubules as observed in cultures of migrating fibroblasts by 
Michael Abercrombie over 40 years ago (Abercrombie et al., 1970, 1971). 
Lamellipodia region of the leading edge is usually defined by an area of ~3-5 μm 
from the extreme front edge and is characterised by dynamic and branched/criss-
crossed polymerised F-actin (Burnette et al., 2011). Actin polymerisation within the 




migration (Ridley et al., 2003). A network of key mediators such as actin related 
protein 2/3 (Arp2/3) complex and its stimulating factors the Wiskott-Aldrich syndrome 
protein (WASP) family regulates lamellipodia F-actin network (Campellone & Welch, 
2010). Arp2/3 complex has been reported to localise throughout the lamellipodium 
but it is only integrated into the network at the front edge of the lamellipodium (Lai et 
al., 2008). WASP (WAVE) proteins localise to the leading edge where it stimulates 
Arp2/3 complex to mediate nucleation and branching of actin filament networks 
(Mullins et al., 1998) critical for lamellipodia extension (Campellone & Welch, 2010). 
The activation of Arp2/3 complex by WASP proteins might be the key regulatory step 
for the incorporation of Arp2/3 complex into the network at the front leading edge of 
the lamellipodium. Other regulators including formins and cofilins have also been 
implicated in lamellipodia extension (Bernard, 2007; Paul & Pollard, 2009; van 
Rheenen et al., 2009; Chesarone et al., 2010; Ridley, 2011). Immediately behind the 
highly dynamic lamellipodia, is the more stable/less dynamic region known as the 
lamella. This region is also wider than the lamellipodia spanning ~10 μm or more in 
width, and is composed of bundled antiparallel F-actin and enriched with myosin II 
(Ponti et al., 2004; Giannone et al., 2007; Burnette et al., 2011; Tsai & Meyer, 2012). 
This region contributes to cell migration by coupling actomyosin contractile network 
with substrate adhesion for traction (Giannone et al., 2004; Ponti et al., 2004; Gupton 
& Waterman-Storer, 2006; Giannone et al., 2007; Burnette et al., 2011; Ridley, 
2011). 
In addition to membrane protrusion, cell migration also requires the formation of cell 
adhesion (Ridley et al., 2003). The dynamics and turnover (i.e. the assembly and 
disassembly) of focal adhesions is critical for cell migration (Webb et al., 2002; 




functional and structural signal transducers that link intracellular cytoskeletal 
structures with the extracellular matrix via integral membrane spanning proteins 
(Webb et al., 2002). Key regulatory proteins of focal adhesions include vinculin, 
paxillin and focal adhesion kinase (FAK); these proteins are also used experimentally 
as markers for focal adhesion (Ziegler et al., 2006; Deakin & Turner, 2008; Mierke, 
2009; Carisey & Ballestrem, 2011; Vicente-Manzanares & Horwitz, 2011; Wehrle-
Haller, 2012; Kim & Wirtz, 2013).  
Migrating cells are polarised and exhibit front-rear polarity, which is characterised by 
broad and ruffling lamellipodia, and filopodia-like protrusions at the front leading 
edge while at the cell rear is the trailing tail (Burnette et al., 2011; Ridley, 2011; 
Dingsdale et al., 2013). Multiple signalling cues converge to co-ordinate the 
regulation of the aforementioned components of specialised network of actin 
modules during cell migration through actions of critical signalling molecules 
including Rho GTPases, phospholipids such as PI(4,5)P2 and kinases such as LIM 
kinase (LIMK) (Ridley, 2011). Rho GTPases are important signal effectors that relay 
signals from cell surface receptors to the actin cytoskeleton (Ridley, 2011). Briefly, 
Rho family of GTPases are small monomeric G-proteins that switch from inactive 
guanosine diphosphate (GDP)-bound conformation to an active guanosine 
triphosphate (GTP)-bound conformation that activates downstream targets. GDP to 
GTP exchange is facilitated by guanine nucleotide exchange factors (GEFs). GTP 
hydrolysis to GDP, which confers Rho GTPases to an inactive form, is accelerated 
and catalysed by GTPase-activating proteins (GAPs) (Bishop & Hall, 2000). The 
major regulatory Rho GTPases are Rac, Cdc42 and RhoA, which acts cooperatively 
or distinctively on different actin modules to control forward membrane extension and 




(Ridley et al., 2003). All three Rho GTPases have been shown to localise in the 
lamellipodia during membrane protrusion (Machacek et al., 2009). RhoA has also 
been shown to localise at the cell rear, where it is essential for tail retraction during 
cell migration (Ridley et al., 2003). Rac primarily regulates lamellipodia extension 
through the activation of WAVE-Arp2/3 complexes. RhoA promotes stress fibre 
formation by mediating the phosphorylation and regulation of myosin II activity. 
Cdc42 regulates filopodia extension and chemosensing (Kaverina et al., 2002; 
Ridley, 2011). These Rho GTPases, in particular Rac and RhoA have been reported 
to undergo activation upon microtubule polymerisation and depolymerisation, 
respectively (Kaverina et al., 2002). Rac- and Cdc42-mediated PAK and LIMK 
phosphorylation and deactivation of cofilin (actin-severing protein) have also been 
reported to be important for actin polymerisation and lamellipodia protrusion 
(Bernard, 2007; Delorme et al., 2007; van Rheenen et al., 2009). In addition, both 
Rac and Cdc42 also regulate the formation of focal adhesion complexes, whereas 
RhoA regulates the maturation of focal adhesions (Kaverina et al., 2002). 
1.3.2 Regulation of cell migration by Ca2+ signalling 
Ca2+ is another critical regulator of cell migration in many if not all cell types 
(Brundage et al., 1991; Berridge et al., 1998; Pettit & Fay, 1998; Berridge et al., 
2000; Wei et al., 2009; Yang et al., 2009; Middelbeek et al., 2012; Tsai et al., 2014). 
Ca2+ signals control cell migration in a multifunctional fashion by regulating 
directional sensing, polarisation, forward movement, cell adhesion and speed (Wei et 
al., 2009; Yang et al., 2009; Middelbeek et al., 2012; Tsai & Meyer, 2012; Tsai et al., 
2014). Just as migrating cells are polarised exhibiting front-rear polarity (Wei et al., 
2009; Dingsdale et al., 2013), both global and local intracellular Ca2+ signals also 




al., 2009; Tsai et al., 2014). In particular, the polarity of local Ca2+ pulses (calcium 
flickers or high-calcium microdomains) with higher frequency in the front than in the 
back of cells control cyclic local lamellipodia membrane protrusion, focal adhesion 
dynamics and turning which are all critical for cell migration (Wei et al., 2009; Tsai & 
Meyer, 2012). Ca2+ signals produced by both IP3R-mediated Ca
2+ release from 
intracellular stores and Ca2+ influx across the PM via SOCE channels Orai1 and TRP 
(TRPM7) channels have all been shown to be critical for the process of migration in 
a number of cell types (Wei et al., 2009; Yang et al., 2009; Middelbeek et al., 2012; 
Schafer et al., 2012; Tsai & Meyer, 2012; Tsai et al., 2014). Interestingly, the 
inhibition of ryanodine receptors (another major intracellular Ca2+ release channels) 
had no effect on regulatory components critical for the migration of human embryonic 
lung fibroblasts (Wei et al., 2009). In addition to a higher frequency of Ca2+ flickers 
(high Ca2+ microdomains) in the front leading edge than in the rear of migrating cells 
(Wei et al., 2009; Tsai et al., 2014) other signalling mechanisms and processes 
including RTK, PLC, DAG, PI(4,5)P2, PI(3,4,5)P3, STIM1 and Orai1 signalling 
together with PM Ca2+ pumps (PMCA) and protein kinase C (PKCβ) signalling have 
all been shown to exhibit front-rear polarisation with preferential localisation to the 
leading edge (Brzeska et al., 2012; Dingsdale et al., 2013; Tsai et al., 2014). 
Collectively, this integrated Ca2+ control system with polarised Ca2+ signalling 
proteins and signalling messengers have been shown to be critical for cell migration 
(Tsai et al., 2014). However and surprisingly, the localisation of IP3Rs in migrating 
cells is not clear; the spatial relationship of IP3Rs and SOCE-competent ER-PM 
junctions has not been characterised; and the spatial and functional relationship 
between IP3Rs and migratory machinery in migrating cells (in particular PDAC) has 





The aims of the present study were: 1) To characterise the redistribution of IP3Rs 
and SOCE-competent ER-PM junctions in PDAC cells during EMT; 2) To examine 
the role of IP3R-mediated Ca
2+ release and SOCE-mediated Ca2+ influx in PDAC cell 
migration; and 3) To examine the spatial and functional relationships between IP3Rs/ 
IP3R-mediated Ca























Chapter 2: Materials and Methods 
2.1 Materials 
2.1.1 Reagents and equipment for pancreatic ductal adenocarcinoma cell line 
(PANC-1) culture and transfection 
Cell culture Dulbecco’s modified Eagle’s medium (DMEM) and supplements 
including heat-inactivated foetal bovine serum (FBS) and PenStrep Glutamine (PSG; 
100x), were all purchased from Life technologies (Paisley, UK). Also 0.05% trypsin 
ethylenediaminetetraacetic acid (EDTA) was purchased from Life technologies 
(Paisley, UK). Phosphate buffered saline (PBS) with no Ca2+ and Mg2+ was 
purchased from Lonza (Verviers, Belgium). Cell culture flasks (25 cm2 and 75 cm2) 
and the cell culture incubator were purchased from Corning (Buckinghamshire, UK) 
and Wolf Laboratories (York, UK), respectively. Transfection reagents including 
PromoFectin and Lipofectamine 2000 were purchased from Promokine (Heidelberg, 
Germany) and Life technologies (Paisley, UK), respectively.  
2.1.2 Chemicals 
Xestospongin-B (inhibitor of IP3-induced Ca
2+ release from intracellular Ca2+ stores) 
was a gift from Dr J. Molgo (Institute of Neurobiology Alfred Fessard, Gif-sur-Yvette 
cédex, France) and GSK-7975A (inhibitor of SOCE (store operated Ca2+ entry)) was 
a gift from Dr Malcolm Begg (GlaxoSmithKline, Stevenage, UK). Cyclopiazonic acid 
(CPA) was purchased from Tocris (Bristol, UK), thapsigargin (TG) and rapamycin 
were purchased from Calbiochem (San Diego, CA, USA). UV-photoactivatable and 
membrane permeant Ins(1,4,5) IP3 (cag-iso-2-145) was purchased from Sichem 




Scientific (Essex, UK). Fluorescent Ca2+ indicators Fura-2 and Fluo-4, and Ca2+ 
chelator BAPTA were all purchased from Life technologies (Paisley, UK). RIPA lysis 
and extraction buffer, Halt protease inhibitor cocktail and EDTA supplements were 
purchased from Pierce-Thermo scientific (Rockford, Illinois, USA). Goat serum, 
bovine serum albumin (BSA), RNAse A and Triton X-100 were all purchased from 
Sigma Aldrich (St. Louis, Missouri, USA). Acetylated BSA was purchased from 
Aurion (Netherlands). Hoechst 33342, Sytox orange and propidium iodide were all 
purchased from Life technologies (Paisley, UK). Small interfering RNA (siRNA) 
oligomers directed against human IP3R1, IP3R2, IP3R3, and STIM1 were all 
purchased from Life technologies (Paisley, UK). In-house designed IP3R1-, IP3R2- 
and IP3R3-isoform specific primers were purchased from Eurofins Genomics 
(Germany). 
2.1.3 Reagents and materials for Immunofluorescence and Immunoblotting 
Primary antibodies used were: anti-IP3R1 (rabbit polyclonal raised against C-terminal 
amino acids 2735-2749 (Dingli et al., 2012), a gift from Prof. J. Parys (Catholic 
University of Leuven, Leuven, Belgium)); anti-IP3R1 [D53A5 (rabbit)] was purchased 
from Cell Signalling Technologies (Danvers, MA, USA); anti-IP3R1 (mouse 
monoclonal, fusion protein corresponding to amino acids 2680-2749 C-terminus of 
rat IP3R1) was purchased from RayBiotech, Inc. (Norcross, GA, USA); anti-IP3R2 
(rabbit polyclonal raised against C-terminal amino acids 2686-2702, a gift from Prof. 
D. Yule (University of Rochester, Rochester, NY, USA)); anti-IP3R3 (mouse) was 
purchased from BD Transduction Laboratories; and anti-PAN IP3Rs rabbit polyclonal 
raised against C-terminal epitope common to all 3 isoforms was purchased from 
Millipore (CA, USA). Anti-green fluorescent protein (GFP) (rabbit and chicken) was 




mouse) was purchased from Zymed Laboratories (Carlsbad, CA, USA). Anti-vinculin 
(mouse), anti-calnexin (rabbit), and anti-β-actin (mouse) were all purchased from 
Sigma Aldrich (St. Louis, Missouri, USA). Anti-E-cadherin (mouse) was purchased 
from Santa-Cruz Biotechnology (Dallas, Texas, USA). Anti-PI(4,5)P2 (mouse) 
antibody was purchased from Abcam (Cambridge, UK). Anti-human Orai1 
extracellular (rabbit) antibody was purchased from Alomone labs (Israel). Anti-STIM1 
(rabbit) antibody was purchased from both Prosci (CA, U.S.A.) and Proteintech-
Europe, and anti-STIM1 (mouse) antibody was purchased from BD Transduction 
Laboratories. Alexa Fluor 647 phalloidin and species-specific fluorophore-conjugated 
secondary antibodies: Alexa Fluor 488, Alexa Fluor 568 and Alexa Fluor 647 were all 
purchased from Life technologies (Paisley, UK). HRP-conjugated secondary 
antibodies (anti-rabbit and anti-mouse species) were purchased from Sigma Aldrich 
(St. Louis, Missouri, USA). 
MOPS running buffer and 4-12% NuPAGE Bis-Tris gradient gel were purchased 
from Life technologies (Paisley, UK). Nitrocellulose membrane was purchased from 
LI-COR Biosciences (Cullman, Alabama, USA). 
2.1.4 Equipment for super-resolution imaging, Boyden chamber migration and 
wound-healing/scratch migration assay 
Oxygen scavenging system for super-resolution dSTORM microscopy – glucose 
oxidase, catalase, cysteamine (mercaptoethylamine) were all purchased from Sigma 
Aldrich (St. Louis, Missouri, USA). Lab-Tek chambered coverglass 8-well ♯ 1.0 with 
low thickness variation was purchased from Thermo Scientific (Runcorn, UK). 
BD Falcon 24-well Boyden chamber PET (polyethylene terephthalate; transparent) 




plates were purchased from Corning (FALCON/Corning, Durham, NC, USA). Cotton 
buds (Johnson’s cotton buds) were purchased from Sainsbury’s local (Liverpool, 
UK). 
µ-Dish 35 mm high glass bottom dishes and cell culture inserts used for wound-
healing/scratch migration assay were purchased form ibidi (Martinsried, Germany). 
2.2 Methods 
2.2.1 Cell culture 
Pancreatic ductal adenocarcinoma (PDAC) cell line PANC-1 was obtained from the 
American Type Culture Collection (ATCC; ATCC number CRL-1469) and cultured in 
DMEM (Dulbecco’s modified Eagle’s medium) supplemented with 10% FBS (foetal 
bovine serum), 100 units/ml penicillin, 100 µg/ml streptomycin and 292 µg/ml 
glutamine. Cultured cells were maintained in a humidified incubator (Wolf 
Laboratories) at 37°C and 5% CO2. 
2.2.2 Constructs, cell transfection and siRNA knockdown 
DNA constructs including YFP-STIM1 with a TK (thymidine kinase) promoter, and 
the rapamycin-inducible constructs with longer helical (LL) linkers were a gift from Dr 
T. Balla (National Institute of Child Health and Human Development, Bethesda, MD, 
USA). YFP-STIM1 with TK promoter was used to reveal endoplasmic reticulum-
plasma membrane (ER-PM) junctions in cells following ER Ca2+ stores depletion. 
Alternatively, rapamycin-inducible linker constructs were used to reveal ER-PM 
junctions in cells with unemptied/unmodified ER Ca2+ stores. The application of the 
rapamycin-inducible linker system has been described before (Varnai et al., 2007). 




mRFP (a plasma membrane-targeted FK506-binding protein coupled to mRFP) and 
ER-targeted CFP-FRB-LL (an endoplasmic reticulum-targeted fragment of 
mammalian target of rapamycin (mTOR) that binds FKBP). The rapamycin-inducible 
linker system is used to reveal the ER-PM junctions via a molecular bridge formed 
between the juxtaposed membranes as a result of the heterodimerisation of the 
FKBP and FRB modules, which can only be established in the presence of 
rapamycin and at sites where the distance between the ER membrane and the PM is 

































Figure 2.1. Rapamycin induces the heterodimerisation of two distinct 
membrane-targeted modules.  
The formation of FKBP-FRB complex is induced only in the presence of rapamycin, 
and at sites where the gap between the juxtaposed membranes is less than 14 nm. 
The FKBP-FRB complex can be revealed as the site of co-localisation of the two 
membrane-targeted fluorophores depicted by red circles (mRFP; monomeric red 





























































In our study we utilised mCherry-labelled paxillin (Pax-mCh) and paxillin labelled with 
Ca2+ sensor GCaMP5 (Pax-GCaMP5). The coding sequence for GCaMP5 was 
obtained from Addgene (plasmid 31788, originally generated by Douglas Kim and 
Loren Looger (Akerboom et al., 2012)). The GCaMP5 coding sequence was PCR 
amplified using the following primer pair containing restriction endonuclease sites 
(underlined) to permit sub-cloning into the pcDNA3.1(+) backbone (Life technologies, 
Paisley, UK) generating a new ‘pcDNA-GCaMP5-CT’ C-terminally tagging 
expression vector: Sense (NotI) 5’-
ATATGCGGCCGCATGACTGGTGGACAGCAAATG-3’; Antisense (ApaI) 5’-
ATATGGGCCCTCACTTCGCTGTCATCATTTGTAC-3’. Paxillin-GCaMP5 was 
created by PCR amplification of the chicken Paxillin sequence obtained from 
Addgene (plasmid 15233, originally deposited by Rick Horwitz (Laukaitis et al., 
2001)) using the following primer pair containing restriction endonuclease sites 
(underlined) to permit sub-cloning into pcDNA-GCaMP5-CT: Sense (EcoRI) 5’-
ATATGAATTCACCATGGACGACCTCGATGCC-3’; Antisense (NotI) 5’-
ATATGCGGCCGCTACAGAAGAGTTTGAGAAAGC-3’. Paxillin-mCherry was 
created by PCR amplification of the chicken paxillin sequence using the following 
primer pair containing restriction endonuclease sites (underlined) for sub-cloning into 
the mCherry-N1 vector (Clontech): Sense (XhoI) 5’-
ATATCTCGAGACCATGGACGACCTCGATGCC-3’; Antisense (EcoRI) 5’-
ATATGAATTCGACAGAAGAGTTTGAGAAAGCA-3’. All constructs were verified by 
automated sequencing (The Sequencing Service, University of Dundee, UK). These 





To exogenously express proteins of interest, cells were transfected at approximately 
60-70% confluence with 1 – 2 µg of DNA per plasmid construct for 24 hours using 
PromoFectin transfection reagent according to the manufacturer’s instructions. 
Briefly, 2 – 4 µl of Promofectin, which was diluted in 100 µl of pre-warmed serum- 
and antibiotic-free medium was added to 1 - 2 µg of DNA diluted in 100 µl of pre-
warmed serum- and antibiotic-free medium, and the DNA-PromoFectin mixture was 
allowed to stand for at least 20 min at room temperature (RT, approximately 18-
22°C) before it was added in a drop-wise manner to PANC-1 cells seeded into 35 
mm dishes (Mattek, Ashland, USA).  
For the knockdown of cellular proteins of interest, siRNA oligomers directed against 
human IP3R1, IP3R2, IP3R3, and STIM1 were used. siRNA sequences targeting 
each of the proteins of interest are: IP3R1 silencer select siRNA sense 5’-
GCACGACAGUGAAAACGCAtt-3’, antisense 5’-UGCGUUUUCACUGUCGUGCct-3’; 
IP3R2 silencer select siRNA sense 5’-GGUGUCUAAUCAAGACGUAtt-3’, antisense 
5’-UACGUCUUGAUUAGACACCag-3’; IP3R3 silencer select siRNA sense 5’-
GCAUGGAGCAGAUCGUGUUtt-3’, antisense 5’-AACACGAUCUGCUCCAUGCtg-
3’; and STIM1 silencer select siRNA sense 5’-GCCUAUAUCCAGAACCGUUtt-3’, 
antisense 5’-AACGGUUCUGGAUAUAGGCaa-3’. Cells were transfected at 
approximately 30-40% confluence with 30 or 50 nM per siRNA oligomer for 72 hours 
using Lipofectamine 2000 transfection reagent according to the manufacturer’s 
instructions. Briefly, 10 µl of Lipofectamine 2000 was diluted in 500 µl of pre-warmed 
Opti-MEM medium and was allowed to incubate for 5 min at RT prior to its addition 
to (12.5 or 15) µl of siRNA oligomer that was diluted in 500 µl of pre-warmed Opti-
MEM medium. The siRNA oligomer-Lipofectamine 2000 mixture was then allowed to 




PANC-1 cells seeded in antibiotic-free DMEM medium in 25 cm2 cell culture flasks. 
Approximately 6 hours after siRNA transfection of PANC-1 cells, antibiotic-free 
medium was replaced with full DMEM cell culture medium (supplemented with 10% 
FBS, 100 units/ml penicillin, 100 µg/ml streptomycin and 292 µg/ml glutamine) for an 
additional 66 hours before cells were harvested for subsequent experiments. 
2.2.3 Quantitative real-time PCR 
Isoform-specific PCR primers for human IP3R1 (NM_001168272.1), IP3R2 
(NM_002223.2) and IP3R3 (NM_002224.3) isoforms were designed in-house based 
on mRNA sequences obtained from both NCBI-PubMed and Uniprot databases. 
Sequences for all 3 isoforms were aligned using Clustal Omega multiple sequence 
alignment online program. Regions of distinct nucleotide sequences for both forward 
and reverse primers of approximately 20–22 bases in length for each IP3R isoform 
with the desired nucleotide base ratio (G-C:A-T) were mapped using Clustal Omega 
multiple sequence alignment and following Netprimer sequence design 
recommendation guide. Selected forward and reverse primer sequences for each 
IP3R isoform were run through an NCBI-BLAST system to be certain that they are 
specific to the individual IP3R isoforms. Forward primers are 22 nucleotides long, 
whereas reverse primers are 20 nucleotides long. Amplicons in other words PCR 
amplified products were 120-200 base pairs (bp) in length based on primers’ 
complimentary binding sites on IP3R mRNA sequences, which can be detected and 
verified on a DNA gel electrophoresis (see Figure 3.2). Primer sequences are: IP3R1 
forward primer 5’-AGAGTTTGGCAAGCGAGTTCCT-3’ and reverse 5’-
CGTGACTCAGCACAGTGACA-3’, amplicon is 171 bp (residues 7783-7953, 
spanning over 2 exon regions); IP3R2 forward primer 5’-




3’, amplicon is 189 bp (residues 5945-6133, spanning over 2 exon regions);  IP3R3 
forward primer 5’-AAGAGCGTGAGAACTCGGAGGT-3’ and reverse 5’-
GCTGAGGACTTGAGCATCTG-3’, amplicon is 201 bp (residues 6334-6535, 
spanning over 3 exon regions); and β-actin (ACTB) forward primer 5’-
CACCTTCTACAATGAGCTGCGTGTG-3’ and reverse5’-
ATAGCACAGCCTGGATAGCAACGTAC-3’ (Faronato et al., 2013), which was used 
as a transcript normaliser. Primers were synthesised by Eurofins Genomics 
(Germany). 
PANC-1 cells seeded to full confluence were lysed, and RNA extracted using a 
QIAGEN RNA Preparation (RNeasy) mini columns extraction kit following the 
manufacturer’s instructions. Following RNA extraction, a Nanodrop reader was used 
to determine the concentration of RNA in μg/μl and RNA purity (a ratio between 
absorbance at 260 nm and 280 nm = ~2.00 arbitrary units). Next, approximately 4 μl 
of RNA sample diluted in 5x loading buffer was run on a 1.2% agarose gel 
electrophoresis at 140 V for 1 hour to verify RNA extraction quality using a Syngene 
Bio-imaging camera system. The presence of two clear bands – the 28S and 18S 
rRNA (ribosomal RNA) subunits on the gel indicated high quality RNA extraction 
(see Figure 3.1). 
Since RNA is relatively unstable, the next step was to reverse transcribe cDNA 
(complementary DNA) from RNA using RevertAid H-minus M-MuLV reverse 
transcriptase enzyme. Briefly, a reaction mixture was prepared in the following way: 
1 μg of RNA, 1 μl Oligo dt (deoxy-thymine nucleotides) primer, 1 μl reverse 
transcriptase and ddH2O (double-distilled H2O) to a total volume of 12 μl, plus 8 μl of 
reaction mix containing 4 μl 5xRT Buffer, 2 μl PCR Nucleotide mix, 0.5 μl RNAsin 




Using a PCR machine the reactions underwent the polymerase chain reaction. The 
cycling parameters were as follows: 
Segment Cycles Temperature (°C) Time (min) 
1 
RNA + dt primer + ddH2O 
1 70  5  
 
2 
5xRT Buffer + PCR Nucleotide mix 
+ RNAsin + ddH2O 






Reverse transcriptase enzyme 





After completion of the cDNA synthesis reaction, a further PCR reaction was 
performed using the synthesised cDNA, and IP3R-isoforms specific forward and 
reverse primers. The product of the PCR reaction was run on a 2% agarose gel at 
120 V for 1 hour to detect and validate the PCR amplified products of each IP3R 
isoform based on the predicted amplicon or PCR amplified product size calculated 
during primer design. 
After the predicted amplicon sizes for each isoform were confirmed on a DNA gel 
(see Figure 3.2), quantitative real-time PCR (qRT-PCR) was performed in triplicate 
to determine the transcript levels of each IP3R isoforms using cDNA, IP3R-isoforms 
specific primers, SYBR Green supermix and an IQ5 real-time PCR detection system 
(Bio-Rad). SYBR Green is a fluorescent dye that binds double-stranded DNA 
(dsDNA). Samples underwent two-step amplification phases at 94°C (0.5 min) and 




(CT) values for each IP3R isoform was determined, and CT value is a measure of the 
amount of DNA in a sample. The CT values for each IP3R isoform transcript was 
normalised to β-actin (ACTB) and relative expression represented as ΔCT.  
2.2.4 Immunoblotting 
After trypsin treatment, detached cells were collected by centrifugation and lysed for 
30 min at 4°C on a rocking mixer using RIPA lysis and extraction buffer 
supplemented with Halt protease inhibitor cocktail and EDTA, which were both used 
at a final concentration of 1:100. After cell lysis, collected supernatant samples were 
diluted with 4% SDS (Sodium dodecyl sulfate) buffer at a ratio of 1:1 and boiled at 
95°C for 5 min to denature or unravel proteins from their native state (i.e. disrupt 
secondary, tertiary and quaternary bonds) into a linearised state. Approximately 30 
µl of samples were separated on a 4-12% NuPAGE Bis-Tris gradient gel for 1 to 2.5 
hours depending on the molecular weight of the protein of interest at 125 V and 
transferred overnight onto nitrocellulose membranes in transfer buffer (2.5 litres of 
ddH2O plus 7.6 g Tris base, 36 g Glycine and 500 ml 100% Methanol). Nitrocellulose 
membranes were blocked in 3% (w/v) non-fat dry skimmed milk powder dissolved in 
PBS (phosphate buffered saline) for 1 hour at RT (room temperature; approximately 
18-22°C), and probed with primary antibodies including anti-IP3R1 (1:500), anti-
IP3R2 (1:1000), anti-IP3R3 (1:500), anti-STIM1 (1:500), anti-ORAI1 (1:200) and anti-
β-actin (1:1000) at 4°C overnight. After overnight incubation, nitrocellulose 
membranes were incubated with appropriate species-specific HRP-conjugated 
secondary antibodies (1:400) for 1 hour at RT. After both primary and secondary 
antibody incubations, nitrocellulose membranes were subjected to a 0.05% Tween-
PBS wash and 3 PBS washes (each wash lasting for 5 min). Both primary and 




PBS-based solution. Prior to visualising blots, nitrocellulose membranes were 
subjected to a further wash in 0.5 M NaCl-PBS solution for at least 15 min at RT to 
remove residual non-specific binding. For siRNA knockdown experiments, blotting 
for β-actin was used as a loading control. Bands were visualised using ECL 
(enhanced chemiluminescence) Western blotting substrate in a Bio-Rad Quantity 
One imaging system. Band intensities were quantified and analysed using Image J 
software. 
2.2.5 Immunofluorescence and confocal microscopy imaging 
Cells seeded into 35 mm glass-bottom dishes (Mattek, Ashland, USA) or µ-Dish 35 
mm high glass bottom dishes (ibidi, Martinsried, Germany) were either non-
transfected or transfected with constructs, and followed with or without drug 
treatment. Briefly, to visualise ER-PM junctions, PANC-1 cells were transfected with 
TK-YFP-STIM1 for 24 hours prior to treatment with 30 μM cyclopiazonic acid (CPA, a 
reversible ER Ca2+-ATPase pump inhibitor) for 1 hour at 37°C / 5% CO2. 
Alternatively, PANC-1 cells were transfected with both PM-targeted LL-FKBP-mRFP 
and ER-targeted CFP-FRB-LL linker constructs (Varnai et al., 2007; Dingsdale et al., 
2013) for 24 hours before treatment with 100 nM rapamycin for 4-5 min at 37°C / 5% 
CO2. Drugs used were diluted to their respective final concentrations in Na
+-HEPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid)-based extracellular solution 
containing (in mM): 140 NaCl, 4.7 KCl, 10 HEPES, 1 MgCl2, 10 glucose, 0.8 – 1.8 
CaCl2 (depending on the nature of experiment), and adjusted to pH 7.3-7.4 using 
NaOH. For example, rapamycin was used in Na+-HEPES-based solution with 1.8 
mM CaCl2, whereas CPA was used in Na
+-HEPES-based solution with 0.8 mM 
CaCl2. Cells were fixed using 4% (v/v; diluted in PBS) paraformaldehyde (PFA) for 




and subsequently permeabilised using 0.2% Triton X-100 (v/v; diluted in PBS) for 5 
min at RT, before an additional 3 PBS washes. Non-specific antibody binding sites 
were blocked for 1 hour at RT in PBS containing 10% (v/v) goat serum and 1% (w/v) 
BSA prior to incubation with primary antibodies in PBS containing 5% (v/v) goat 
serum and 0.1% (v/v) acetylated BSA for 1 hour at RT or overnight at 4°C. Primary 
antibodies were used at the following dilutions: anti-IP3R1, 1:200; anti-IP3R2, 1:100; 
anti-IP3R3, 1:100; anti-PAN IP3Rs, 1:20; anti-vinculin, 1:200; anti-GFP, 1:200; anti-
PIP2, 1:100; anti-occludin, 1:100; anti-E-cadherin, 1:50; and anti-calnexin, 1:100. In 
specified experiments Alexa Fluor 647 phalloidin was used at a dilution of 1:50. Post-
primary antibody incubation, cells were PBS washed 3 times followed by the addition 
of appropriate species-specific fluorophore-conjugated secondary antibodies for 30 
min at RT at dilutions of 1:500–1:1000 in PBS. Additional 3 PBS washes were 
carried out prior to imaging in PBS or PBS-0.02% azide. All fluorescently conjugated 
secondary antibodies used in the present study were tested on PFA-fixed PANC-1 
cells without the use of a primary antibody (also known as “no primary antibody 
control”). None of these fluorescently conjugated secondary antibodies produced any 
staining in PANC-1 cells. 
Two different confocal microscopes were used in the present study to visualise fixed 
and immuno-stained cells. A Leica acousto-optical beam splitter (AOBS) TCS SP2 
confocal microscope with HCX PL APO Ibd.BL 63x OIL immersion objective, 
numerical aperture = 1.4. The other was a Zeiss Laser Scanning Microscope LSM 
710 confocal microscope with Plan-Apochromat 63x oil objective (63x/1.4oil DIC 
M27) with a numerical aperture of 1.4. The pinhole was set between 1-2 airy units, 




512 pixels per frame unless otherwise stated. Scale bars represent 10 µm unless 
otherwise stated.  
2.2.6 Live-cell imaging, Ca2+ imaging and uncaging 
Ca2+ imaging experiments were performed on live cells. PANC-1 cells seeded to 
approximately 60-70% confluence in glass bottom dishes were loaded with either 5 
µM Fura2-AM or 5 µM Fluo4-AM Ca2+ indicators. 
To investigate IP3-induced Ca
2+ responses in PANC-1 cells, cells were dual-loaded 
with 1 µM UV-photoactivatable and membrane permeant Ins(1,4,5)P3 (caged 
Ins(1,4,5)P3/PM) and 5 µM fluo4-AM in Na
+-HEPES-based extracellular solution 
containing 1.8 mM Ca2+ in the absence or presence of Xestospongin B (inhibitor of 
IP3-induced Ca
2+ release) at RT for 1 hour. Then followed by 2 washes in Na+-
HEPES-based 1.8 mM Ca2+ extracellular solution, before an additional 30 min 
incubation in Na+-HEPES-based 1.8 mM Ca2+ extracellular solution at RT to allow for 
the adaptation and de-esterification phase of fluorophore fluo4-AM to occur. Prior to 
imaging, Na+-HEPES-based 1.8 mM Ca2+ extracellular solution was replaced with 
Na+-HEPES-based nominally Ca2+ free extracellular solution to be certain that the 
cytosolic Ca2+ responses observed following un-caging of caged Ins(1,4,5)P3 
originated only from intracellular Ca2+ stores. Recordings were acquired on a Zeiss 
Laser Scanning Microscope LSM 510 confocal microscope with maximally opened 
pinhole (corresponding to 7.94 airy units) using a 63x Water objective with a 
numerical aperture of 1.2; 4% power of UV laser- (351 and 364 nm) and 0.7% power 
of 488 nm laser-lines were used. Uncaging of caged Ins(1,4,5)P3 was performed at 
several uncaging iterations i.e. the duration of uncaging, which ranged from 3 to 20 




2.2.7 Boyden Chamber Migration assay 
Untransfected or transfected PANC-1 cells were subjected to both symmetric (1% 
FBS in both upper and lower chambers) and asymmetric (chemotactic; 0% FBS in 
upper chamber and 5% FBS in lower chamber) Boyden chamber cell migration 
assay for 6 hours in a humidified environment at 37°C / 5% CO2 in the presence or 
absence of the inhibitors of specific Ca2+ signalling complexes. Inhibitors used were 
the inhibitor of SOCE (store operated Ca2+ entry) GSK-7975A and the inhibitor of 
IP3-induced Ca
2+ release from intracellular Ca2+ stores Xestospongin-B. No FBS (0% 
FBS)-treated group was employed as a negative control for the Boyden chamber cell 
migration assay. In addition, chemotactic Boyden chamber cell migration assay (0% 
FBS in upper chambers and 5% FBS in lower chambers) was also performed on 
PANC-1 cells after 72-hour siRNA knockdown of IP3R1, IP3R2, IP3R3, or STIM1 
proteins.  
Briefly, for both symmetrical and asymmetrical FBS distribution cell migration 
experiments, approximately 50,000 cells were seeded into each of the upper 
chambers of Boyden chamber PET or Fluoroblok inserts with 8 µm pore size, and 
were allowed to migrate through the porous membrane for 6 hours. After 6 hours 
incubation, Boyden chamber inserts were fixed using 100% methanol for 10 min. 
Boyden chamber inserts were then washed in PBS for 10 min and non-migrated 
cells were removed from the top-side of the chamber inserts using cotton buds and 
rinsed 2 times in PBS. Boyden chamber inserts were incubated in PBS solution, 
which contained 10 µg/ml RNAse A for 30 min prior to incubation in PBS solution 
containing 100 µg/ml propidium iodide for 10 min. Once more, after propidium iodide 
staining, any residual non-migrated cells were removed from the top-side of the 




the Boyden chamber inserts were imaged on a Leica AOBS TCS SP2 confocal 
microscope using a HC PL FLUOTAR 10x DRY objective with a numerical aperture 
of 0.3 (Burdyga et al., 2013). Five regions of interest were imaged per Boyden 
chamber insert and these regions collectively represent the majority (~70%) of the 
total surface area of each chamber membrane that was analysed. Fluorescently-
stained migrated cells were counted using a CellProfiler cell counting algorithm 
software.  
2.2.8 Wound-healing/Scratch migration assay 
Ibidi µ-Dish 35 mm high glass bottom or 35 mm glass bottom dishes (Mattek) were 
used. Ibidi cell culture inserts were placed into the above-mentioned glass bottom 
dishes before non-transfected PANC-1 cells were seeded into either side of the 
inserts. Approximately 24 hours after cell seeding, the cells reached full confluence 
and the inserts were then carefully removed with a tweezers creating a defined open 
gap or ‘wound’ of approximately 500 µm. The defined open gap or ‘wound’ area was 
imaged at time=0 immediately after cells were incubated in 0% FBS medium or in 
1% FBS medium supplemented with or without the inhibitors of specific Ca2+ 
signalling complexes. Cells were then allowed to migrate for 18 hours into the open 
space of ‘wound’ area in a humidified environment at 37°C / 5% CO2; and at the end 
of experiment at time=18 hours, the corresponding ‘wound’ area containing migrated 
cells was imaged. This experiment was performed on a Leica AOBS TCS SP2 
confocal microscope using a HC PL FLUOTAR 10x DRY objective (numerical 






2.2.9 Testing effects of Xestospongin-B and GSK-7975A on cell viability 
To investigate the effect of the Ca2+ signalling inhibitors (Xestospongin-B and GSK-
7975A) on cell viability, PANC-1 cells seeded into 35 mm glass bottom dishes were 
treated with / without 50 µM Xestospongin-B or 30 µM GSK-7975A for 6 hours at 
37°C / 5% CO2 to mimic the condition employed for the Boyden chamber migration 
assays. Incubation conditions were grouped into 0% FBS DMEM, 1% FBS-
supplemented DMEM (control), 1% FBS-supplemented DMEM with 50 µM 
Xestospongin-B and 1% FBS-supplemented DMEM with 30 µM GSK-7975A. 
Following the initial 6h incubation, PANC-1 cells were briefly co-incubated for 20 min 
with 10 µg/ml Hoechst 33342 to stain cellular nuclei for total cell count and 0.5 µM 
Sytox orange to stain cellular nuclei of cells with compromised plasma membrane at 
37°C / 5% CO2 prior to live-cell imaging. Hoechst 33342 and Sytox orange were 
prepared in 1.8 mM Ca2+-containing Na+-HEPES-based extracellular solution. Live 
images were acquired on a Leica AOBS TCS SP2 confocal microscope with pinhole 
corresponding to 2 airy units. HC PL FLUOTAR 20x DRY objective with a numerical 
aperture of 0.5 was used in these experiments. The number of live cells was 
calculated by subtracting Sytox orange-stained positive cells (dead cells) from 
Hoechst-stained positive cells (total cell count). Mean ± SEM was obtained from at 
least 3 independent experiments. 
2.2.10 Super-resolution imaging 
For super-resolution imaging, PANC-1 cells were seeded into Lab-Tek chambered 
coverglass 8-well ♯ 1.0 with low thickness variation (Thermo Scientific, Runcorn, 
UK). To visualise IP3R1 at super-resolution level, PANC-1 cells were fixed with 4% 




followed by the use of an appropriate species-specific Alexa Fluor 647 secondary 
antibody. To visualise ER-PM junctions at super-resolution level, PANC-1 cells were 
co-transfected with PM-targeted LL-FKBP-mRFP and ER-targeted CFP-FRB-LL 
linker constructs and incubated for 24 hours. The cells were then fixed using 4% 
PFA for 10-15 min at RT after treatment with 100 nM rapamycin for 4-5 min at 37°C / 
5% CO2 to reveal the pre-existing ER-PM junctions without ER Ca
2+ store depletion. 
Briefly, the heterodimerisation of both ER- and PM-targeted constructs reveal the 
ER-PM junctions as punctate structures in both CFP and RFP fluorescence 
channels. To reveal the ER-FRB-LL-CFP counterpart of the ER-PM junctions’ puncta 
at super-resolution level, ER-FRB-LL-CFP counterpart of the ER-PM linker construct 
was immunostained using anti-GFP antibody (which also recognizes CFP), and 
followed by appropriate species-specific Alexa Fluor 647 secondary antibody. Better 
quality super-resolution images are best acquired in the red-absorbing part of the 
visible light spectrum (Dempsey et al., 2011), and hence an Alexa Fluor 647 
secondary antibody was used to amplify anti-GFP primary antibody staining, which 
was used to highlight ER-FRB-LL-CFP accumulated in ER-PM junctions.  
After immunostaining of IP3R1 or ER-PM junctions, samples were immersed and 
imaged in a dSTORM buffer containing 100 U/ml glucose oxidase, 2000 U/ml 
catalase, 50 mM mercaptoethylamine-HCl and 50 mg/ml glucose in PBS (Metcalf et 
al., 2013). Wells were filled and sealed with a cover slip to exclude oxygen. Briefly, 
super-resolution microscopy was performed using a custom-built instrument, as 
described previously (Metcalf et al., 2013; Ferraro et al., 2014). An Olympus IX71 
formed the basis of an inverted TIRF instrument with a UAPON 100XOTIRF, 
NA=1.49 objective. Laser illumination was provided by a 640 nm, 150mW, diode 




laser (Coherent Europe B.V.). Additionally, a 405 nm laser diode (Mitsubishi 
Electronics Corp.) was available for re-activation of fluorophores if required. Laser 
power on the diode lasers was controlled directly, whereas a rotating quarter-wave 
plate was used to alter the power of the 561 nm laser. Lower powers (1-10%) were 
used for field of view selection, context and conventional fluorescence images. High 
powers (50-100%) were used for dSTORM imaging. Fluorescence and excitation 
light were spectrally separated by the dichroic mirror and emission filter from a multi-
edge filter set (LF405/488/561/635-A-000, Semrock (Rochester, NY, USA)), and an 
additional band pass filter was used to remove cross-talk in each channel (FF01-
676/37 with 640 nm excitation and FF01-600/37 with 561 nm excitation, both from 
Semrock (Rochester, NY, USA)). 
Images were acquired using an EMCCD camera (Andor iXon 897, Belfast, UK) using 
software written in LabVIEW (National Instruments). Typically dSTORM image 
“stacks” was composed of 10000 frames, with 10 ms exposure time per frame. 
Super-resolution images were reconstructed from these image stacks using the 
open-source rainSTORM package (Metcalf et al., 2013). The super-resolution 
microscopy experiments were performed in collaboration with Dr Alex Knight and Dr 
Daniel Metcalf at the National Physical Laboratory (Middlesex, London, UK). 
2.2.11 Image, data and statistical analyses 
Image acquisition and preliminary analysis was performed using either Leica LAS or 
Zeiss LSM 510 or Zeiss Zen software. Further analysis was performed using Image 
J software. Linear adjustments of contrast and brightness were applied if necessary 
using Image J. The ‘mask’ images (labelled ER&PM linkers) used for illustrating the 




Co-localise RGB Image J plugin as described before (Dingsdale et al., 2013). Briefly, 
this Image J plugin determines the presence of co-localised pixels between ER- and 
PM-linker images after threshold values were adjusted for each image of interest. 
For statistical analysis of two groups of measurements unpaired t-test with a two-
tailed distribution and unequal variance was applied. For experiments involving more 
than two groups, one-way ANOVA with Bonferroni test was applied. p<0.05 was 
considered statistically significant and indicated by symbol * on the graphs. All 
individual experiments were repeated at least 3 times (i.e. from at least 3 separate 
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Chapter 3: The expression and distribution of IP3Rs and ER-PM 
junctions in pancreatic ductal adenocarcinoma cells 
3.1 Epithelial phenotype and monolayer 
Epithelial cells are known for their organisation into adherent groups established as 
single cell layers or multilayer tissues with several vital functions including secretory 
and protective roles (Rodriguez-Boulan & Nelson, 1989; Huang et al., 2012). 
Epithelial cells have to be polarised to execute these specialised functions and thus 
exhibit apical-basal polarity and communicate with each other via specialised cell-
cell or intercellular junctions known collectively as epithelial intercellular junctional 
complexes (IJCs) (Nelson, 2009). IJCs maintain and stabilise epithelial integrity and 
are sub-grouped into tight junctions (TJs), adherens junctions (AJs) and 
desmosomes (Farquhar & Palade, 1963; Steed et al., 2010; Terry et al., 2010). TJs 
are localised at the subapical end of the lateral membrane and are composed of 
integral membrane spanning proteins including occludin, junction adhesion 
molecules (JAMs) and claudins, and the cytoplasmic auxiliary proteins zonula 
occludens (ZO-1, ZO-2, and ZO-3). TJs function as bi-directional signalling 
transducers as well as dynamic barriers to regulate paracellular permeability and as 
a molecular fence to maintain epithelial integrity and polarity by restricting the 
intermixing of apical and basolateral membrane components (Steed et al., 2010; 
Terry et al., 2010). AJs and desmosomes contribute to maintaining cell-cell adhesion 
and are located predominantly within the lateral membrane and are composed of 
integral membrane spanning proteins such as epithelial cadherin (E-cadherin) and 
desmosomal cadherin, respectively (Yap et al., 2007; Terry et al., 2010; Lamouille et 




particular E-cadherin are Ca2+ binding proteins (Shapiro & Weis, 2009), and the 
polarity and integrity of epithelial intercellular junctions have been shown in MDCK 
cells by Mauger and colleagues to be dependent on Ca2+ signalling (Colosetti et al., 
2003). Ca2+ signals are known to be regulated by Ca2+ signalling complexes, which 
prominently involve the interplay of Ca2+ release from intracellular stores primarily via 
IP3Rs and RyRs, and Ca
2+ replenishment via store operated Ca2+ entry (SOCE) 
channels localised at the ER-PM junctions (Carrasco & Meyer, 2011). In this part of 
the study, the subcellular distribution of Ca2+ signalling complexes (IP3Rs and 
STIM1-competent ER-PM junctions) in monolayers of pancreatic ductal 
adenocarcinoma cells (PDAC; specifically PANC-1) was examined. 
3.2 Expression of endogenous IP3Rs in PANC-1 cells 
The aim of this part of the study was to determine the expression profiles and define 
the distribution(s) of Ca2+ signalling complexes (IP3Rs and STIM1-competent ER-PM 
junctions) in PDAC cells. Pancreatic ductal cells are epithelial cells lining the 
pancreatic duct, which functions as secretory exocrine cells of the pancreas and 
specifically recognised for their role in fluid and electrolyte secretion (Steward et al., 
2005; Pandol, 2010). PDAC probably arises from pancreatic acinar cells (PAC), 
which assume ductal phenotype (Rooman & Real, 2012). PANC-1 cells are 
established from pancreatic carcinoma of ductal origin and were used as a model 
cell line to examine the expressions and distributions of Ca2+ signalling complexes. 
Preliminary experiments were carried out to determine whether IP3Rs are 
endogenously expressed in PANC-1 cells at both mRNA (messenger RNA) and 
protein levels. To probe the expression of IP3Rs at mRNA level, total RNA was 




electrophoresis. The presence of two clear bands – the 28S and 18S rRNA 
(ribosomal RNA) subunits indicated high quality RNA extraction (Figure 3.1). In 
quantitative real time PCR (qRT-PCR) analysis, it was observed that PANC-1 cells 
endogenously express all 3 isoforms (subtypes) of IP3R at mRNA level (Figures 3.2 
and 3.3). The relative expression of all 3 isoforms of IP3R at mRNA level varies with 
IP3R3 (36.6%) greater than both IP3R1 (32.2%) and IP3R2 (31.2%) (Figure 3.3). 
Next, the expression of all 3 isoforms of IP3R at the protein level was examined, and 
it was convincingly established from the Western blot profiles that all 3 isoforms are 
endogenously expressed at detectable levels in PANC-1 cells using isoform specific 
antibodies (Figure 3.4). All 3 isoforms of IP3R migrate with similar electrophoretic 
mobilities, and hence exhibit similar apparent molecular weights (Figure 3.4). 
The experimental data shows that PDAC cells endogenously express all 3 isoforms 










Figure 3.1. Total RNA isolated from pancreatic ductal adenocarcinoma (PANC-1) 
cells. 
PANC-1 cells were lysed, RNA contents extracted and analysed by gel 
electrophoresis. The quality of RNA extraction is detected as two strong clear bands – 



















Figure 3.2. mRNA transcripts of IP3R isoforms in pancreatic ductal 
adenocarcinoma cells.  
PANC-1 cells were lysed, RNA contents extracted and processed into cDNA using 
reverse transcriptase enzyme. Amplicons are PCR amplified products based on 
targeting primers, and are typically between 120-200 base pairs in length. Shown are 
the representative gel profiles for actin and each IP3R isoform. Note - these gel 
profiles are indication of the presence of each isoform of IP3R rather than the 

























































Figure 3.3. Relative amount of IP3Rs mRNA levels in pancreatic ductal 
adenocarcinoma cells. 
PANC-1 cells were lysed, RNA contents extracted and processed into cDNA. The 
amount of IP3Rs mRNA levels was determined by quantitative real time RT-PCR 
using IP3R-isoform specific primers, cDNA and SYBR DNA-binding fluorescent dye. 
The cycle threshold (C
T
) value for each IP3R isoform was determined and CT value is 
a measure of the amount of DNA in a sample (note that smaller C
T 
values correspond 
to larger DNA content). The C
T
 value for each IP3R isoform transcript was normalised 














Figure 3.4. Expression of IP3R proteins in pancreatic ductal adenocarcinoma 
cells. 
PANC-1 cells were lysed, contents collected by centrifugation, separated on SDS-







The molecular weights of all IP
3




3.3 IP3Rs expressed in PANC-1 cells are functional Ca
2+ release 
channels 
After the expression profiles of IP3R isoforms were established in our model cell line 
PANC-1, the next step was to determine whether or not these IP3Rs were functional 
Ca2+ release channels. To test the Ca2+ releasing function of endogenously 
expressed IP3Rs in PANC-1 cells, UV-photoactivatable and membrane permeant 
Ins(1,4,5) IP3 (caged IP3) was utilised. PANC-1 cells were co-loaded with both caged 
IP3 and Ca
2+ indicator Fluo-4, and pulses of UV light used to induce IP3 uncaging 
and subsequent release of Ca2+ from intracellular stores into the cytosol. In these 
experiments nominally Ca2+ free extracellular solution was used to reveal cytosolic 
Ca2+ responses occurring specifically due to Ca2+ release from IP3-sensitive 
intracellular stores. Figure 3.5 shows that UV-uncaged IP3 induced Ca
2+ release from 
intracellular stores (red trace; red arrows on the image fragments show the 
fluorescence of Fluo-4 before, during and after uncaging). No detectable Ca2+ 
response (black trace; blue arrows on the image fragments) was observed in control 
cells that were not UV illuminated. Furthermore, to demonstrate that the Ca2+ 
responses observed after pulses of UV light induced uncaging were released 
primarily through IP3Rs in PANC-1 cells, a selective IP3R inhibitor Xestospongin-B 
(Jaimovich et al., 2005; Criollo et al., 2007) was utilised. Xestospongin-B strongly 
inhibited IP3-induced Ca
2+ release from intracellular stores of PANC-1 cells (Figure 
3.6). 
These experimental findings convincingly demonstrate that the Ca2+ fluxes following 









Figure 3.5. IP3 induces Ca
2+
 release from intracellular Ca
2+ 
stores in pancreatic 
ductal adenocarcinoma cells. 
Ca
2+
 release from intracellular stores were measured in cells loaded with caged IP
3
 
and Fluo-4. Caged IP
3
 can only be activated in the presence of UV illumination in 
pancreatic ductal adenocarcinoma cells. Pulse of UV light induced uncaging (i.e. 
release of IP
3
 from its caged precursor) and subsequent release of Ca
2+
 from 
intracellular stores into the cytosol. These are representative traces composed from 
normalised values for individual time points of Fluo-4 fluorescence measurements. 
Red trace depicts UV-illuminated cell (indicated by red arrows on the image 
fragments), whereas black trace depicts the cell, which was not exposed to UV light 
(indicated by blue arrows on the image fragments). Red arrows on the image 
fragments outline fluorescence of Fluo-4 before, during and after uncaging. The black 
arrow indicates the duration of uncaging (~8s). In these experiments nominally Ca
2+
 
free extracellular solution was used to reveal cytosolic Ca
2+
 responses occurring 
specifically due to Ca
2+















































































Figure 3.6. Xestospongin-B blocks IP3-induced Ca
2+
 release in pancreatic ductal 
adenocarcinoma cells.  
Ca
2+
 release from intracellular stores were measured in cells loaded with caged IP
3
 in 
the absence (control; red trace, 28 cells) or presence of 50 μM Xestospongin-B (blue 
trace, 29 cells). The traces were composed from normalised mean values ± SEM for 
individual time points of Fluo-4 fluorescence measurements. Pulses of UV light 
induced uncaging (i.e. release of IP
3
 from its caged precursor) and subsequent 
releases of Ca
2+
 from intracellular stores into the cytosol. The intensities of the black 
arrows indicate the durations of uncaging (3s, 8s and 20s). In these experiments 
nominally Ca
2+
 free extracellular solution was used to reveal cytosolic Ca
2+
 responses 
occurring specifically due to Ca
2+




3.4 Distribution of IP3Rs in connected PANC-1 cells 
After successfully demonstrating that PANC-1 cells endogenously express all 3 
isoforms of IP3R, and these IP3Rs are functional IP3-induced Ca
2+ release channels, 
we sought to examine the subcellular distribution and localisation of each isoform of 
IP3R in PANC-1 cells. Cultured PANC-1 cells usually grow in a monolayer fashion 
after reaching full confluence in any defined space (i.e. standard culture vessels), 
and exhibit an epithelial phenotype. Using immunofluorescence and confocal 
microscopy applications, E-cadherin (adherens junction marker) and occludin (tight 
junction marker) staining were used to reveal and validate the establishment of the 
epithelial phenotype of PANC-1 cells in monolayer cultures (Figures 3.7 and 3.8). 
The fluorescence profile of E-cadherin localisation measured along the line spanning 
the cell-cell contacts region demonstrate approximately 40-times increase in the 
density of E-cadherin staining at the cell-cell contact region in comparison with the 
adjacent regions of the cytoplasm (Figure 3.7, lower panel) in connected PANC-1 
cells, and this observation resembles the fluorescence profile of occludin localisation 
in connected PANC-1 cells (Figures 3.8, lower panel). After the epithelial phenotype 
of PANC-1 cells in monolayer culture was established, the distribution of IP3R 
isoforms was visualised. IP3R1 shows a polarised distribution and appears to be 
primarily localised at the cell-cell contacts region in PANC-1 cell monolayer (Figure 
3.9). A similar polarised distribution of IP3R1 at cell-cell contacts was observed in 
smaller PANC-1 cell clusters (Figure 3.10). Fluorescence profiles measured along 
the line spanning the cell-cell contacts region demonstrate 4-7 times increase in the 
density of IP3R1 at the cell-cell contacts region in comparison with the neighbouring 




localisation of IP3R1, both IP3R2 and IP3R3 exhibit perinuclear localisation in clusters 
of PANC-1 cells (Figures 3.11 and 3.12; see also Figures 3.15 and 3.16).  
These experimental findings demonstrate that isoforms of IP3R exhibit differential 











Figure 3.7. The polarised distribution of E-cadherin (adherens junction marker) 
in connected pancreatic ductal adenocarcinoma cells.  
E-cadherin is localised at the cell-cell contact sites of PANC-1 cells forming a 
confluent monolayer. PANC-1 cells were fixed and immunostained using anti-E-
cadherin antibody. Fluorescence profile (bottom panel) was measured along the line 
spanning the cell-cell contact region. Scale bar represents 10 µm. Merge - indicates 
the overlay of fluorescence and DIC images. 
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Figure 3.8. The polarised distribution of occludin (tight junction marker) in 
connected pancreatic ductal adenocarcinoma cells.  
Occludin is localised at the cell-cell contact sites of PANC-1 cells forming a confluent 
monolayer. PANC-1 cells were fixed and immunostained using anti-occludin antibody. 
Fluorescence profile (bottom panel) was measured along the line spanning the cell-
cell contact region. Scale bar represents 10 µm. Merge - indicates the overlay of 












Figure 3.9. The polarised distribution of IP3R1 in connected pancreatic ductal 
adenocarcinoma cells.  
IP
3
R1 are localised at the cell-cell contact sites of PANC-1 cells forming a confluent 
monolayer. PANC-1 cells were fixed and immunostained using anti-IP
3
R1 antibody. 
Fluorescence profile (right panel) was measured along the line spanning the cell-cell 
contact region. Scale bar represents 10 µm. 
IP3R1
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Figure 3.10. The polarised distribution of IP3R1 in connected pancreatic ductal 
adenocarcinoma cells.  
IP
3
R1 are localised at the cell-cell contact sites in cluster of PANC-1 cells. PANC-1 
cells were fixed and immunostained using anti-IP
3
R1 antibody. Fluorescence profile 
(right panel) was measured along the line spanning the cell-cell contact region. Scale 










R2 are preferentially localised to the perinuclear region in PANC-1 cell cluster. 
PANC-1 cells were fixed and immunostained using anti-IP
3
R2 antibody. Scale bar 





















R3 is enriched in the perinuclear region in cluster of PANC-1 cells. Right panel 
shows the fragment indicated by the white arrowhead on the left panel. PANC-1 cells 
were fixed and immunostained using anti-IP
3





3.5 IP3R1 localises to cell-cell contact sites in PANC-1 cell 
monolayer and clusters 
Following the interesting observation that IP3R1 appears to be localised at the cell-
cell contact region in connected PANC-1 cells, I sought to establish that the regions 
of IP3R1 accumulation were indeed the cell-cell contact junctions. Dual 
immunostaining using anti-IP3R1 and anti-E-cadherin antibodies showed that IP3R1s 
co-localised with E-cadherin at the cell-cell contact region in connected PANC-1 cells 
(Figure 3.13). Note the yellow colour on the ‘Merge’ image of Figure 3.13, indicating 
that in contact regions, IP3R1 and E-cadherin are so closely positioned that the 
distance between the proteins is below the resolution of a confocal microscope (i.e. 
<300 nm). Dual immunostaining with anti-IP3R1 and anti-occludin antibodies similarly 
highlighted that IP3R1s co-localise with occludin at the cell-cell contact region in 
connected PANC-1 cells (Figure 3.14).  Fluorescence profiles measured along the 
lines spanning cell-cell contacts also shows the close positioning of IP3R1 and 
occludin in cellular contact regions (Figure 3.14, lower panel). Note the white colour 
on the ‘Merge’ image of Figure 3.14, indicating that in the cellular contact regions, 
the distance between IP3R1 and occludin is below the resolution of a confocal 
microscope. In contrast to IP3R1, IP3R2 and IP3R3 are not preferentially localised to 
the cellular contact regions revealed by occludin staining in connected PANC-1 cells 
(Figures 3.15 and 3.16). 
Our experimental findings strongly suggested that IP3R1 was localised at cell-cell 
contacts and co-localised or closely co-positioned with adherens and tight junction 
markers in connected PDAC cells, whereas both IP3R2 and IP3R3 are perinuclear-




suggests that the isoforms of IP3R could exhibit different structural and functional 
roles in monolayer or clusters of PDAC cells depending on their subcellular 
localisations. 
  
Figure 3.13. IP3R1 co-localise with E-cadherin (adherens junction marker) at the 
cell-cell contact sites in cluster of pancreatic ductal adenocarcinoma cells.  
PANC-1 cells were fixed and co-immunostained using anti-IP
3
R1 and anti-E-cadherin 
antibodies. Scale bar represents 10 µm. Fluorescence profile (bottom panel) that 
illustrates juxtaposition of the proteins was measured along the line spanning the cell-
cell contact region. Fluorescence intensity shown was normalised to the maximum 
fluorescence for each individual staining. 
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Figure 3.14. IP3R1 co-localise with Occludin (tight junction marker) at the cell-
cell contact sites in cluster of pancreatic ductal adenocarcinoma cells.  
PANC-1 cells were fixed and co-immunostained using anti-IP
3
R1 and anti-occludin 
antibodies. Scale bar represents 10 µm. Fluorescence profile (bottom panel) that 
illustrates juxtaposition of the proteins was measured along the line spanning the cell-
cell contact region. Fluorescence intensity shown was normalised to the maximum 










R2 is preferentially localised to the perinuclear region and does not co-localise with 
occludin (tight junction marker) in PANC-1 cell cluster. PANC-1 cells were fixed and 
co-immunostained using anti-IP
3
R2 and anti-occludin antibodies. Scale bar 











R3 is predominantly enriched in the perinuclear region and does not co-localise 
with occludin (tight junction marker) in PANC-1 cell cluster. PANC-1 cells were fixed 
and co-immunostained using anti-IP
3
R3 and anti-occludin antibodies. Scale bar 




3.6 Expression of endogenous STIM1 and Orai1 in PANC-1 cells 
Following plasma membrane receptor-stimulated phosphatidylinositol 4,5-
bisphosphate (PI(4,5)P2) hydrolysis, inositol 1,4,5-trisphosphate (IP3) production, 
stimulation of IP3Rs, and subsequent Ca
2+ release through IP3Rs in the endoplasmic 
reticulum (ER), ER Ca2+ concentration ([Ca2+]ER) can become depleted; restoring 
([Ca2+]ER) after such Ca
2+ release events involve store operated Ca2+ entry (SOCE) 
mediated by stromal interaction molecule (STIM), which activates plasma membrane 
(PM) ion channel Orai to permit influx of Ca2+. This process of activation takes place 
in specialised ER-PM junctions (Wu et al., 2006; Lur et al., 2009; Carrasco & Meyer, 
2011). This process of Ca2+ replenishment is particularly important for non-excitable 
cells, which do not possess voltage-gated Ca2+ channels (VGCCs) (Berridge et al., 
1998; Schindl et al., 2009). In the non-excitable PDAC cell line PANC-1, I sought to 
determine whether or not the key components of SOCE – STIM1 and Orai1 proteins 
are endogenously expressed. From the Western blot profiles, it could be 
demonstrated that both STIM1 and Orai1 were endogenously expressed in PANC-1 
cells at protein level (Figure 3.17). Furthermore, a selective small molecule inhibitor 
(GSK-7975A) of Orai1 channels (Derler et al., 2013) was used to demonstrate that 
these endogenously expressed key players of SOCE are functional in mediating 
Ca2+ influx following ER Ca2+ store depletion in PANC-1 cells (unpublished results 
obtained by T. Parker in our laboratory, data not shown). 
Collectively, these experimental findings show that PDAC cells endogenously 
express STIM1 and Orai1 proteins, and that these proteins are capable of mediating 













Figure 3.17. Expression of the key components of store operated Ca
2+
 entry 
(SOCE) process: STIM1 and Orai1 proteins in pancreatic ductal 
adenocarcinoma cells. 
PANC-1 cells were lysed, contents collected by centrifugation, separated on SDS-
PAGE, and immunoblotted using anti-STIM1 and anti-Orai1 antibodies. The molecular 





3.7 Localisation of IP3R1 and ER-PM junctions in connected PANC-
1 cells 
Following the determination that PANC-1 cells endogenously express functionally 
competent IP3R Ca
2+ release channels and STIM1-Orai1 complexes, I next sought to 
examine simultaneously the subcellular localisations and distributions of IP3Rs and 
SOCE-competent ER-PM junctions in connected PANC-1 cells by 
immunofluorescence and confocal microscopy. To visualise SOCE-competent ER-
PM junctions, PANC-1 cells were transfected with TK-YFP-STIM1 for 24 hours prior 
to treatment with 30 μM CPA for 1 hour at 37°C / 5% CO2. Alternatively, PANC-1 
cells were transfected with both PM-targeted LL-FKBP-mRFP and ER-targeted CFP-
FRB-LL linker constructs (Varnai et al., 2007; Dingsdale et al., 2013) for 24 hours 
before treatment with 100 nM rapamycin for 4-5 min at 37°C / 5% CO2. After 
revealing ER-PM junctions by these methods, cells were fixed and immunostained 
with anti-IP3R1 antibody. 
In connected PANC-1 cells, IP3R1 was, as previously localised in cell-cell contacts 
whilst ER-PM junctions revealed by STIM1 puncta formation following ER Ca2+ store 
depletion with CPA (Figure 3.18) or by co-localised ER and PM linkers without ER 
Ca2+ store depletion (Figure 3.19), could be found in the closely adjacent cytosolic 
region. As I had previously demonstrated IP3R1 co-localisation with the tight junction 
marker occludin in connected PANC-1 cells (Figure 3.14), the relative positioning of 
occludin and STIM1-competent ER-PM junctions was next examined in connected 
PANC-1 cells. Similar to the observed relative positioning of IP3R1 and ER-PM 
junctions, STIM1-competent ER-PM junctions were found in a closely adjacent 
region next to tight junctions (i.e. tight junctions are spatially segregated from the 




this observation, the relative positioning of tight junctions (occludin) and ER 
bulk/strands (revealed by calnexin staining) was visualised. It was found that ER 
strands decrease in density towards the cell periphery and project as far as the area 
that is closely adjacent to tight junctions (Figure 3.21). This observation could 
perhaps explain why STIM1-competent ER-PM junctions do not co-localise with tight 
junctions but instead are positioned in close proximity to cell-cell contacts. 
These experimental findings show that both IP3R1 and ER-PM junctions are 
localised at the cell periphery with IP3R1 localised at cell-cell contacts spatially 









Figure 3.18. Relative positioning of IP3R1 and STIM1 puncta in connected 
pancreatic ductal adenocarcinoma cells.  
In connected PANC-1 cells IP
3
R1 are localised in cell-cell contacts region whilst ER-
PM junctions revealed by STIM1 puncta formation following ER Ca
2+
 store depletion 
with cyclopiazonic acid (CPA), can be found in closely adjacent region. Upper panels 
show the distribution of IP
3
R1 and STIM1 in connected cells. Confocal images were 
taken from the cellular regions adjacent to the coverslip. Scale bar represents 10 µm. 








Figure 3.19. Relative positioning of IP3R1 and ER-PM junctions in connected 
pancreatic ductal adenocarcinoma cells.  
In connected PANC-1 cells IP
3
R1 are localised in cell-cell contacts region whilst ER-
PM junctions revealed by co-localised ER and PM linkers can be found in closely 
adjacent region. Upper panels show the distribution of IP
3
R1 and ER-PM junctions in 
3 connected cells. Confocal images were taken from the cellular regions adjacent to 
the coverslip. Scale bar represents 10 µm. Lower panel show the fragment outlined 







Figure 3.20. Relative positioning of occludin (tight junction marker) and STIM1 
puncta in connected pancreatic ductal adenocarcinoma cells. 
Tight junction marker occludin is spatially segregated from ER-PM junctions (revealed 
by STIM1 puncta formation) in PANC-1 cell cluster. TK-YFP-STIM1-transfected 
PANC-1 cells were fixed after treatment with CPA and immunostained with anti-
occludin antibody. Scale bar represents 10 µm. Lower panel show the fragment 














Figure 3.21. Relative positioning of occludin (tight junction marker) and 
calnexin (ER marker) in connected pancreatic ductal adenocarcinoma cells. 
Tight junction marker occludin is spatially segregated from peripheral ER strands 
(revealed by calnexin staining) in PANC-1 cell cluster. PANC-1 cells were fixed and 
co-immunostained with anti-occludin and anti-calnexin antibodies. Scale bar 





This part of the present study has successfully shown that all 3 isoforms of IP3R, and 
store operated Ca2+ entry (SOCE) components STIM1 and Orai1 proteins are 
endogenously expressed in PDAC cells (Figures 3.4 and 3.17). With the use of 
caged IP3 and selective IP3Rs inhibitor Xestospongin-B (Figure 3.6), it was 
successfully demonstrated that these IP3Rs are functional Ca
2+ channels capable of 
mediating IP3-induced Ca
2+ release from intracellular stores in PANC-1 cells. 
Furthermore, I also successfully characterised the subcellular distribution of all 3 
isoforms of IP3R, and the relative positioning of polarised IP3Rs and STIM1-
competent ER-PM junctions in connected polarised PANC-1 cells.  
Ca2+ is a remarkable, versatile and universal signalling ion known for its crucial role 
in numerous cellular processes including proliferation, differentiation and secretion 
(Berridge et al., 1998; Berridge et al., 2000). Ca2+ is able to mediate a vast number 
of cellular processes. Its versatility is most likely due to the ability of this remarkable 
ion to form numerous specific complex spatial and temporal patterns (Berridge et al., 
2000). IP3Rs are important platforms for Ca
2+ signals, and it has been postulated by 
Vermassen et al. (2004) that the exact subcellular localisation of IP3Rs determines 
the physiological consequences of IP3-induced Ca
2+ release, which is subsequently 
important for the correct initiation and propagation of Ca2+ signals. 
To map the exact subcellular localisations of IP3Rs in polarised connected PANC-1 
cells, firstly, it was established that the 3 isoforms of IP3R present in PANC-1 cells at 
mRNA level exhibited differential expression profiles with IP3R3 been the most 
abundant isoform whereas IP3R2 was the least abundant isoform. This data is in 




presence or abundance of each isoform of IP3R is cell type dependent and IP3R 
isoforms are expressed in different proportions in different cell and tissue types. I 
also established that these IP3Rs are functional Ca
2+ release channels in PANC-1 
cells by using the most selective inhibitor of IP3Rs channels available Xestospongin-
B (Jaimovich et al., 2005; Criollo et al., 2007). Xestospongin-B is a member of the 
Xestospongins family; a macrocyclic bis-1-oxaquinolizidines isolated from the marine 
sponge Xestospongia exigua (Quirion et al., 1992; Jaimovich et al., 2005). 
Xestospongin-B has been demonstrated to be a potent membrane-permeable 
inhibitor of IP3Rs (Gafni et al., 1997; Jaimovich et al., 2005; Criollo et al., 2007). The 
selectivity and fidelity of Xestospongin-B acting specifically on IP3Rs and inhibiting 
IP3-induced Ca
2+ release from intracellular Ca2+ stores (primarily the ER) has been 
demonstrated in HeLa cells and rat skeletal myotubes by the Molgo group, where 
they elegantly showed that Xestospongin-B had no effect on the following Ca2+ 
signalling events and Ca2+ regulatory processes: ER Ca2+ leak, [Ca2+]ER and basal 
[Ca2+]C level, Ca
2+ ATPase pump activity or thapsigargin action, and store operated 
Ca2+ entry after ER Ca2+ store depletion with thapsigargin (Jaimovich et al., 2005; 
Criollo et al., 2007). 
Interestingly, isoforms of IP3R exhibit differential subcellular localisations in clusters 
and monolayers of polarised PANC-1 cells. IP3R1 is predominantly localised at cell-
cell contact junctions as demonstrated by its remarkable co-localisation with occludin 
and E-cadherin in connected PANC-1 cells. IP3R2 and IP3R3 are primarily localised 
at the perinuclear region in connected PANC-1 cells. In support of the differential 
subcellular distribution of isoforms of IP3R we observed in PANC-1 cells, a number 
of previous reports have shown that isoforms of IP3R exhibit diverse subcellular 




epithelial cell types for example in pancreatic acinar cells (PACs), all 3 isoforms of 
IP3R are predominantly concentrated near the apical membrane where they co-
localised with tight junction markers ZO1 and occludin (Nathanson et al., 1994; Lee 
et al., 1997; Yule et al., 1997; Lur et al., 2009; Lur et al., 2011). This region has been 
demonstrated to be functionally important as a trigger zone in which Ca2+ waves 
originate, and subsequently mediates a number of cellular processes including fluid 
secretion and exocytosis (Thorn et al., 1993; Ito et al., 1997; Lee et al., 1997; Yule et 
al., 1997). In cholangiocytes, both IP3R1 and IP3R2 were found uniformly distributed 
in the cytoplasm whereas IP3R3 was primarily found near the apical membrane 
(Hirata et al., 2002a). In liver hepatocytes where two isoforms of IP3R are expressed, 
IP3R2 can be found near the apical membrane (canalicular), while the other isoform 
(IP3R1) was found uniformly distributed in the cytoplasm (Dufour et al., 1999; Hirata 
et al., 2002b). In vascular smooth muscle cells, IP3R1 was localised throughout the 
cytoplasm, IP3R2 was localised near the plasma membrane and also in the 
perinuclear region, and IP3R3 was only found in the perinuclear region (Tasker et al., 
2000). In confluent, polarised and fully differentiated non-tumourigenic Madin-Darby 
canine kidney (MDCK) cells, exogenously expressed IP3R1 in addition to the 
predominantly endogenously expressed isoform IP3R3 have both been shown to 
primarily localise in the vicinity of tight junctions (Colosetti et al., 2003; Dingli et al., 
2012). Interestingly, these IP3Rs have been shown not to always co-localise with ER 
markers but instead with PM markers such as tight/adherens junction markers in 
MDCK and PACs (Colosetti et al., 2003; Lur et al., 2011; Dingli et al., 2012). IP3Rs in 
liver cells have also been shown not to co-purify or fractionate with ER markers but 
instead with PM markers e.g. alkaline phosphodiesterase 1 (Rossier et al., 1991). 




from previous works, it is clear that the distribution of isoforms of IP3R varies widely 
in epithelial cells, suggesting that the subcellular localisation of IP3Rs and IP3-
induced Ca2+ release sites are important determinants of the spatial and temporal 
characteristics of Ca2+ signals. Such signals in turn likely regulate different epithelial 
functions including but not limited to the regulation of paracellular diffusion/tight 
junction permeability, fluid and electrolyte secretion, exocytosis, and cell 
proliferation/differentiation. 
In the present study, the importance of tight junctions for IP3Rs localisation was not 
investigated. However, from reviewing elegant work by Colosetti et al. (2003) and 
others, one could speculate on the possible relationship between the tight junctions 
and IP3Rs localisation. In MDCK cells the most abundantly expressed isoform of 
IP3R is IP3R3 (Colosetti et al., 2003; Dingli et al., 2012). Monitoring the establishment 
of polarity by measuring trans-epithelial resistance (TER), it was shown that the 
concentration of IP3R3 in the close vicinity of tight junctions is positively dependent 
on the cellular polarity state of MDCK cells (Colosetti et al., 2003). Using a calcium 
switch experiment (i.e. polarised MDCK cells were placed in Ca2+ free medium for 
several hours and then replaced in Ca2+ supplemented medium), Colosetti et al. 
(2003) showed that polarity was dynamically lost and re-established, respectively. 
The former was accompanied by disruption of tight junctions and IP3R3 was 
localised in the cytoplasm. During re-establishment of polarity, re-localisation of tight 
junction marker ZO-1 to intercellular junctions was rapid and preceded that of IP3R3, 
the latter occurring only after intercellular junctions were well established (TER of 
≥200 ohm cm2), suggesting that the localisation of IP3Rs at intercellular junctions 




intercellular junctions is most likely a secondary event that is required for providing 
Ca2+ signals needed for functioning of epithelium. 
In view of the remarkable polarised distribution of IP3R1 at cell-cell contacts region in 
connected polarised PANC-1 cells, the studies presented in this chapter were 
focused on the distribution of IP3R1. Following ER Ca
2+ store emptying through IP3R 
Ca2+-release channels in the ER, restoring of the [Ca2+]ER involves SOCE mediated 
by STIM1, which activates PM channels Orai1 to permit influx of Ca2+, and this Ca2+ 
refilling process takes place in the ER-PM junctions (Wu et al., 2006; Varnai et al., 
2007; Lur et al., 2009; Carrasco & Meyer, 2011). ER-PM junctions are a specialised 
region of close contact with an inter-membrane space of 7 to 25 nm between the two 
organelles (Wu et al., 2006; Varnai et al., 2007; Lur et al., 2009; Orci et al., 2009; 
Carrasco & Meyer, 2011; Chang et al., 2013; Wu et al., 2014), which serves as 
signalling hubs for Ca2+ signalling (Wu et al., 2006; Varnai et al., 2007; Lur et al., 
2009; Chang et al., 2013; Wu et al., 2014), phosphatidylinositol transfer and 
signalling (Carrasco & Meyer, 2011; Manford et al., 2012; Chang et al., 2013) and 
cAMP signalling (Lefkimmiatis et al., 2009; Willoughby et al., 2012). In the present 
study, I successfully showed that SOCE components – STIM1 and Orai1 proteins 
are endogenously expressed in PANC-1 cells (Figure 3.17). I next examined the 
subcellular distribution of Ca2+ releasing sites in relation to that of Ca2+ 
replenishing/reloading sites in PANC-1 cells in greater detail. It was observed that 
both IP3R1 and STIM1/SOCE-competent ER-PM junctions exhibit a polarised 
distribution and localise in the cell periphery area of connected PANC-1 cells. 
Notably, STIM1/SOCE-competent ER-PM junctions (Ca2+ replenishing platform) do 






Thus, it can be reasoned that Ca2+ releasing sites are strategically positioned with 
respect to Ca2+ replenishing sites, creating a stratified distribution of Ca2+ signalling 
complexes in the vicinity of intercellular junctions in connected PDAC cells. This 
further suggests that coordination of strategically positioned SOCE-competent ER-
PM junctions and IP3R1 mediated Ca
2+ release platforms may cooperatively provide 
and sustain prolonged Ca2+ signalling. The functions of these Ca2+ signals have not 
been investigated in this study but one can speculate that these signals could play a 
role in establishing/maintaining epithelial phenotype or on the contrary in soliciting 
epithelial-mesenchymal transition (EMT). Ca2+ signalling in the proximity of tight 
junctions could be also important for epithelial functions like exocytotic and fluid 
secretion (Rodriguez-Boulan & Nelson, 1989; Ito et al., 1997; Steward et al., 2005; 
Pandol, 2010; Huang et al., 2012). 
 
 










Chapter 4: Redistribution of IP3Rs and ER-PM junctions in pancreatic 













Chapter 4: Redistribution of IP3Rs and ER-PM junctions in 
pancreatic ductal adenocarcinoma cells during epithelial-
mesenchymal transition 
4.1 Epithelial-mesenchymal transition 
PDAC is the 4th leading cause of cancer-related mortalities worldwide (Siegel et al., 
2011), with poor prognosis and a median survival period of less than 12 months after 
diagnosis (Siegel et al., 2013). The poor outcome of this cancer is characterised by 
its aggressive, disseminated, metastatic nature and strong resistance to 
chemotherapy (Stathis & Moore, 2010; Siegel et al., 2013). The metastatic nature of 
PDAC and other cancer types is associated with epithelial-mesenchymal transition 
(EMT) (Chang et al., 2012), migration and invasion (Hanahan & Weinberg, 2011; 
Lamouille et al., 2014). 
EMT is the conversion of epithelial cells into mesenchymal cells, and external cues 
such as growth factors e.g. epidermal growth factor (EGF), the transforming growth 
factor family e.g. TGFβ and extracellular matrix components e.g. fibronectin and 
collagen have been shown to be key mediators of this process (Nelson, 2009; Terry 
et al., 2010; Lamouille et al., 2014). EMT is characterised by the apparent change in 
cellular phenotypes after trans-differentiation from apical-basal polarity to front-rear 
polarity (Lamouille et al., 2014). SNAIL, zinc-finger-E-box-binding (ZEB), and basic 
helix-loop-helix (bHLH) transcription factors have been reported to regulate the 
process of the EMT switch at a transcriptional level. In addition, regulatory factors of 
the EMT switch are also regulated at post-transcriptional, translational and post-
translational levels (Chang et al., 2012; Lamouille et al., 2014). During EMT, 




epithelial signatures by disassembly of intercellular junctional complexes (IJCs) and 
loss of apical-basal polarity. There is a concomitant up-regulation of genes that 
define the formation of new front-rear cellular polarity permitting trans-differentiation 
into motile mesenchymal cells (Lamouille et al., 2014). The loss of epithelial IJCs is 
accompanied by the dissolution of tight junction markers claudins, occludin and ZO-1 
and adherens junction marker E-cadherin (Chang et al., 2012). Desmosome markers 
as well as markers for polarity complexes (comprising of Crumbs complex, 
partitioning defective (PAR) and Scribble complex) are also lost from the intercellular 
junction area (Nelson, 2009; Lamouille et al., 2014). Concomitantly, mesenchymal 
gene markers including N-cadherin, vimentin and fibronectin as well as genes that 
define the remodelling of the actin cytoskeleton are up-regulated leading to the 
formation of lamellipodia, filopodia and invadopodia to increase cell motility and 
invasive phenotypes of mesenchymal cells (Ridley et al., 2003; Chang et al., 2012; 
Lamouille et al., 2014). A number of recent studies have reported the importance of 
Ca2+ signalling for EMT (Davis et al., 2014), cell adhesion, cell motility and invasion 
in a number of different cell types (Wei et al., 2009; Yang et al., 2009; Middelbeek et 
al., 2012; Tsai & Meyer, 2012; Tsai et al., 2014). The efficient Ca2+ signalling 
mediated by IP3Rs requires [Ca
2+]ER reloading mechanisms, which involve Ca
2+ 
sensor STIM1 and PM Ca2+ channel Orai1 that are localised in the ER-PM junctions 
(Carrasco & Meyer, 2011), and some types of TRP channels are probably also 
involved (Worley et al., 2007). In this part of the study, we induced transition from 
epithelial to mesenchymal phenotype and investigated the changes in the distribution 






4.2 During EMT PANC-1 cells change cellular morphology 
Having established that PANC-1 cells in a monolayer exhibit apical-basal polarity 
and cell-cell contact junctions, which are classic characteristic features of the 
epithelial phenotype, I next sought to examine any observable change(s) in PANC-1 
cells’ morphology and phenotype during EMT. ‘Wounding’ of cellular monolayers is 
known to induce EMT (Nelson, 2009; Lamouille et al., 2014). Using wound-healing or 
scratch migration assay with ibidi cell culture inserts, I observed dramatic changes in 
the morphology of PANC-1 cells during EMT. The formation of new cellular (front-
rear) polarity is characterised by thin and long (red and yellow arrows in Figure 4.1) 
or wide and short (white arrow in Figure 4.1) tails at the rear, while broad and ruffling 
lamellipodia and filopodia protrusions formed at the front leading edges of migrating 
PANC-1 cells (Figure 4.1). PANC-1 cells in migratory mode exhibit smooth-like 
lamellipodia (Figure 4.1, yellow arrowhead) or a complex of smooth-like lamellipodia 
and spiky protrusions at the leading edges (Figure 4.1, red and white arrowheads). 
This experimental finding demonstrates that PDAC cells undergo profound 







Figure 4.1. The differential phenotypes/morphologies of pancreatic ductal 
adenocarcinoma cells (PANC-1) in connected monolayer versus migration 
modes.  
Significant changes in the morphology of PANC-1 cells were observed as these cells 
transit between connected monolayer and migration modes. PANC-1 cells in 
migration modes exhibit smooth-like lamellipodia leading edges (yellow arrowhead), 
or a complex of smooth-like lamellipodia and spiky protrusions at the leading edges 
(red and white arrowheads) with thin and long tails (red and yellow arrows) or with 
wide and short tails (white arrow). PANC-1 cells were seeded into either side of the 
ibidi cell culture inserts, and allowed to reach full confluence. The insert was carefully 
removed creating a defined open gap of approximately 500 µm, and PANC-1 cells 
were allowed to migrate for 6 hours at 37°C / 5% CO
2




4.3 IP3Rs exhibit differential subcellular distribution in migrating 
PANC-1 cells 
In light of the above findings I next sought to determine the fate and distribution of 
Ca2+ signalling complexes (i.e. IP3Rs) during EMT in PDAC cells. Using wound-
healing or scratch migration assays with ibidi cell culture inserts to induce EMT, and 
subsequent immunostaining for IP3R1 (Figure 4.2), I observed profound changes in 
the subcellular localisation of IP3R1. IP3R1 underwent remarkable translocation from 
the cell-cell contact region in connected PANC-1 cells to preferentially localise at the 
leading edge of migrating PANC-1 cells (Figure 4.2A). Fluorescence profiles 
measured along the lines spanning the cell membrane of the leading edge regions 
show that IP3R1 preferentially accumulated at the leading edge and in the spiky 
filopodia-like protrusions at the front of migrating PANC-1 cells (Figure 4.3, upper 
and lower panels). A similar polarised distribution of IP3R1 with increased density at 
the leading edge of migrating PANC-1 cells was also observed using a second 
commercially obtained anti-IP3R1 antibody, suggesting that the redistribution was a 
specific phenomenon (Figure 4.4). Immunostaining for IP3R2 highlighted a similar 
polarised distribution in migrating PANC-1 cells (Figure 4.5). In contrast to the 
observed polarised distribution of IP3R1 and IP3R2, IP3R3 maintained its enriched 
distribution in the perinuclear region after EMT (Figure 4.6) in spite of the dramatic 
morphological changes observed in PANC-1 cells during EMT. Fluorescence profile 
measured along the line spanning the cell membrane of the leading edge region 
show that the density of IP3R3 distribution increased towards the perinuclear region 
(Figure 4.6, right panel). Consistent with this, the fluorescence profile of IP3R3 
showed an inverse relationship to those of IP3R1 and IP3R2 in migrating PANC-1 




4.7a show confocal sections taken from ventral parts of the cells located in the 
immediate proximity to the coverslip. Pan-IP3Rs antibodies (raised against a 
conserved region in the C terminal of all subtypes of IP3R) also revealed a similar 
polarised distribution of IP3Rs (most likely IP3R1 and IP3R2) with preferential 
localisation at the leading edge of individual migrating cells (Figure 4.7a). In addition, 
visualising IP3R distribution at the ventral (bottom z-plane, in close proximity to the 
coverslip), middle and dorsal (top z-plane, furthest distance from the coverslip) parts 
of PANC-1 cells using the Pan-IP3Rs antibody interestingly provided further evidence 
that IP3Rs localise to different subcellular regions within migrating PANC-1 cells, with 
a population of receptors at the periphery (consistent with data obtained with type I 
and type II specific antibodies) and another population in a perinuclear region 
(consistent with data obtained with type III specific antibody and to a certain extent 
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Individual migrating cellsConnected cells
Figure 4.2. The polarised distribution of IP3R1 in connected and migrating cells, 
and the procedure used to change the cellular phenotype.  
(A). Illustrates the translocation of IP
3
R1 from cell-cell contacts (upper left panel) to 
the leading edge (upper right panel) of PANC-1 cells. An example of preferential 
accumulation of IP
3
R1 at the leading edge in a cell that was induced to migrate as a 
result of removal of the insert (see part B) is shown on the upper right panel. Scale 
bars represent 10 µm. 
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Distance along the line (m)
Figure 4.3. IP3R1 predominantly decorates the leading edge of pancreatic ductal 
adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and immunostained using anti-IP
3
R1 antibody. 
Migrating PANC-1 cells with a smooth-like lamellipodia leading edge (top panel), and 
with a combination of smooth-like lamellipodia and spiked protrusions at the leading 
edge (bottom panel). Fluorescence profiles (right panels) were measured along the 
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Figure 4.4. Distribution of IP3R1 in individual migrating pancreatic ductal 
adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and immunostained using anti-IP
3
R1 antibody 
(commercially obtained antibody). The right panel of the figure shows the 
fluorescence distribution along the line spanning the cell membrane of the leading 
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Figure 4.5. Distribution of IP3R2 in individual migrating pancreatic ductal 
adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and immunostained using anti-IP
3
R2 antibody. The 
right panel of the figure shows the fluorescence distribution along the line spanning 
the cell membrane of the leading edge region (shown on the left panel). Scale bar 












These experimental results show that profound morphological changes including the 
formation of new cellular polarity in PDAC cells were observed after EMT, and this 
was accompanied by the redistribution of IP3Rs, with IP3R1 and IP3R2 undergoing 
redistribution from cell-cell contacts and perinuclear regions in connected PANC-1 
cells, respectively, to preferentially localise at the leading edge region of migrating 
PANC-1 cells. In contrast, IP3R3 retained its enriched perinuclear localisation after 
EMT. The observed redistribution of IP3R1 and IP3R2 in migrating cells suggest that 
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IP3R3
Figure 4.6. Distribution of IP3R3 in individual migrating pancreatic ductal 
adenocarcinoma cells. 
In polarised PANC-1 cells, IP
3
R3 are richly localised to the perinuclear region and 
somewhat in the cytosolic region. Polarised PANC-1 cells were fixed and 
immunostained using anti-IP
3
R3 antibody. The right panel of the figure shows the 
fluorescence distribution along the line spanning the cell membrane of the leading 




IP3R1 and IP3R2 (but less likely IP3R3) could be important for the migration of 
pancreatic ductal adenocarcinoma cells (see chapter 5). 
  
  
Figure 4.7a. IP3Rs predominantly decorate the leading edge of pancreatic ductal 
adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and immunostained using anti pan-IP3R antibody. 
Fluorescence profile (right panel) was measured along the line spanning the cell 
membrane of the leading edge region (shown on the left panel). Scale bar represents 
10 µm. 





































Figure 4.7b. Differential distribution of IP3Rs in migrating pancreatic ductal 
adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and immunostained using anti pan-IP3R antibody. 
Bottom, middle and top panels represent the Z-positions, with the bottom z-position 
being the nearest to the coverslip. Pan-IP3Rs antibody interestingly provided further 
evidence that IP3Rs localise to different subcellular regions within migrating PANC-1 





4.4 Distribution of STIM1 / ER-PM junctions in migrating PANC-1 
cells 
Having established from previous experiments that EMT of PDAC cells is 
accompanied by the formation of new cellular polarity and profound changes in the 
distribution of cellular Ca2+ signalling components i.e. IP3Rs, I sort to determine the 
distribution of STIM1-competent ER-PM junctions in actively migrating PANC-1 cells. 
After the exogenous expression of rapamycin-inducible ER and PM linker constructs 
in PANC-1 cells without ER Ca2+ store depletion or modification, we observed that 
ER-PM junctions preferentially accumulate at the leading edge of migrating PANC-1 
cells (Figure 4.8, middle panel). ER & PM linker image (shown as white dotes, 
bottom panel of Figure 4.8) was created to highlight ER-PM junctions revealed by 
the regions of co-localisation of the ER and PM linker constructs using the Image J 
co-localise RGB plugin described previously (Dingsdale et al., 2013). Alternatively, 
following the exogenous expression of TK-YFP-STIM1 in PANC-1 cells and ER Ca2+ 
store depletion using ER Ca2+-ATPase inhibitor CPA, we observed that STIM1 
puncta (highlighting ER-PM junctions) accumulated and decorated the leading edge 
of migrating PANC-1 cells (Figure 4.9). Similar observations have been reported by a 
number of studies including Dingsdale et al. (2013) and Tsai et al. (2014). Dingsdale 
et al. (2013) further demonstrated that STIM1-competent ER-PM junctions form at 






Figure 4.8. Distribution of ER and PM linker constructs before and after 
treatment with rapamycin in live migrating pancreatic ductal adenocarcinoma 
cells. 
PANC-1 cells co-transfected with PM-targeted LL-FKBP-mRFP and ER-targeted 
CFP-FRB-LL linker constructs were imaged live on a confocal microscope before and 
during the addition of 100 nM rapamycin. ER & PM linker images (bottom panel) were 
created to highlight ER-PM junctions revealed by the region of co-localisation of the 


























Figure 4.9. STIM1 puncta decorates the leading edge of migrating pancreatic 
ductal adenocarcinoma cells. 
PANC-1 cells transfected with TK-YFP-STIM1 were treated with CPA and imaged on 




The increased density of STIM1-competent ER-PM junctions at the leading edge of 
migrating PANC-1 cells was a surprising observation. A possible explanation for this 
phenomenon is increased density of ER strands (and consequently higher probability 
of ER-PM junction formation). Therefore, I next examined the distribution of the ER 
network in migrating PANC-1 cells. We observed that the distribution of ER-density 
(revealed by calnexin staining) exhibited an inverse relationship to the distribution of 
ER-PM junctions (revealed by STIM1 puncta) i.e. the density of ER network 
decreased towards the cell periphery whilst the density of ER-PM junctions 
increased towards the cell periphery (Figures 4.10a and 4.10b). 
These experimental findings show that STIM1-competent ER-PM junctions 
redistribute from sites closely adjacent to cell-cell contact junctions in connected 
PANC-1 cells to the leading edge of migrating PANC-1 cells. In addition, it was also 
observed that the distribution of ER-PM junctions (revealed by STIM1 puncta) 
exhibited an inverse relationship to the distribution of ER-density in migrating PANC-
1 cells. The proximity of STIM1-competent ER-PM junctions to the leading edge 







Figure 4.10a. Relative distribution of ER-PM junctions and ER-density in 
migrating pancreatic ductal adenocarcinoma cells. 
PANC-1 cells transfected with TK-YFP-STIM1 were fixed and immunostained with 
anti-calnexin antibody following ER Ca
2+
 store depletion using CPA. Scale bar 
represents 10 µm. Middle and bottom panels show the fragments outlined by the 
rectangles in the upper panel (Merge). 





































































Figure 4.10b. STIM1 puncta gradient versus ER-density gradient in migrating 
pancreatic ductal adenocarcinoma cells.  
The distribution of ER-PM junctions (revealed by STIM1 puncta) exhibits an inverse 
relationship to the distribution of ER-density in migrating PANC-1 cells. 
Measurements of average calnexin fluorescence ± SEM and STIM1 puncta were 




4.5 Localisation of IP3R1 and ER-PM junctions in migrating PANC-1 
cells 
After observing the redistribution of Ca2+ signalling complexes (i.e. IP3Rs and STIM1-
competent ER-PM junctions) in PANC-1 cells following EMT, the distributions of both 
IP3R1 and ER-PM junctions were simultaneously examined in migrating cells. PANC-
1 cells were transfected with TK-YFP-STIM1 for 24 hours prior to treatment with 30 
μM CPA for 1 hour at 37°C / 5% CO2. Alternatively, PANC-1 cells were transfected 
with both PM-targeted LL-FKBP-mRFP and ER-targeted CFP-FRB-LL linker 
constructs (Varnai et al., 2007; Dingsdale et al., 2013) for 24 hours before treatment 
with 100 nM rapamycin for 4-5 min at 37°C / 5% CO2. After revealing ER-PM 
junctions by these methods, cells were fixed and immunostained with anti-IP3R1 
antibody. In migrating PANC-1 cells IP3R1 decorated the leading edge whilst STIM1 
puncta/ER-PM junctions concentrated in a closely adjacent region (just behind the 
leading edge) (Figures 4.11 and 4.12). All images show confocal sections taken from 








Figure 4.11. Relative positioning of IP3R1 and STIM1 / ER-PM junctions in 
migrating pancreatic ductal adenocarcinoma cells. 
In migrating PANC-1 cells IP
3
R1 decorate the leading edge whilst STIM1 puncta 
concentrate in the adjacent region (just behind the leading edge). PANC-1 cells were 
transfected with TK-YFP-STIM1 and then treated with 30 µM CPA to reveal STIM1 
puncta. Cells were then fixed and immunostained using anti-IP
3
R1 antibody. All 
images show confocal sections taken from ventral parts of the cells located in the 
immediate proximity to the coverslip. Scale bar represents 10 µm. Bottom panel show 







Figure 4.12. Relative positioning of IP3R1 and ER-PM junctions (ER&PM linkers) 
in migrating pancreatic ductal adenocarcinoma cells. 
In migrating PANC-1 cells IP
3
R1 decorate the leading edge whilst ER-PM junctions 
concentrate in the adjacent region (just behind the leading edge). PANC-1 cells were 
transfected with both linker constructs ER-targeted CFP-FRB-LL and PM-targeted LL-
FKBP-mRFP and then treated with 100 nM rapamycin to reveal ER-PM junctions. 
Cells were then fixed and immunostained using anti-IP
3
R1 antibody. Scale bar 
represents 10 µm. Bottom panel show the fragment outlined by the rectangle in left 




Furthermore, the preferential localisation of IP3R1 and ER-PM junctions at the front 
of migrating cells was also confirmed using super-resolution microscopy (Dempsey 
et al., 2011; Metcalf et al., 2013). In these experiments, employing dSTORM 
technique, we observed that the leading edge of migrating cells indeed had an 
increased density of IP3R1 (Figure 4.13) and higher concentration of ER-PM 
junctions (Figure 4.14a). Note the increased resolution of dSTORM images (in x-y 
plane) in comparison to diffraction limited (in x-y plane) TIRF images taken from the 
same cellular regions (high magnification fragments in Figures 4.13, 4.14a and 
4.14b). The actual size of both ER-PM junctions and clusters of IP3R1 are 
significantly smaller than the limit of resolution of diffraction-limited microscopy but 
the preferential localisation at the leading edge was observed using all types of 
microscopy. dSTORM imaging, which has considerably improved axial and lateral 
resolution (60-70 nm) in comparison with conventional microscopy (~300 nm), 
confirmed that both IP3R1 and ER-PM junctions can be observed close to the 
leading edge and in the immediate proximity to the ventral membrane of the 
migrating cells (i.e. portion of the membrane which is involved in forming contacts 
with the substratum and sliding along the substratum). 
These experimental data show that STIM1-competent ER-PM junctions are 
positioned just behind IP3R1s at the leading edge, creating a stratified distribution of 
Ca2+ signalling complexes at the front of migrating PDAC cells. In addition, the 
observed stratified distribution of Ca2+ signalling complexes at the leading edge 
suggests that these complexes could be important for the migration of PDAC cells 





Figure 4.13. Positioning of IP3R1 in migrating pancreatic ductal 
adenocarcinoma cells imaged at super-resolution level. 
Super-resolution microscopy of IP
3
R1 at the leading edge of a PANC-1 cell. Left 
panel shows the leading edge of a cell immunostained using antibody against IP
3
R1 
and imaged using a TIRF microscope (“diffraction-limited” refers to its lateral 
resolution). Scale bar corresponds to 1 µm. The fragment, highlighted as a square on 
the left panel, was then imaged using dSTORM and the result is shown on the central 
panel. Scale bar corresponds to 1 µm. Right panel (Merge) shows co-positioning of 
the two images. Expanded fragments on the middle and bottom panels are taken 
from the peripheral regions indicated by arrowheads on the ‘Merge’ (left arrowhead 
corresponds to the middle set of images). Note the improvement of resolution in 
comparison with diffraction limited images (left panels). Lateral dSTORM resolution in 














  Figure 4.14a. Positioning of ER-PM junctions (ER&PM linkers) in migrating 
pancreatic ductal adenocarcinoma cells imaged at super-resolution level. 
Super-resolution microscopy of ER-PM junctions near the leading edge of PANC-1 
cells. PANC-1 cells transfected with both linker constructs (PM-targeted FBKP-LL-
mRFP and ER-FRB-LL-CFP) were fixed after treatment with 100 nM rapamycin to 
highlight the pre-existing ER-PM junctions without ER Ca
2+
 store depletion. PANC-1 
cells were then stained using anti-GFP antibody (which also recognizes CFP) to 
reveal ER-FRB-LL-CFP accumulated in ER-PM junctions. Left panel shows 
localisation of ER-PM junctions visualised using a TIRF mode (“diffraction-limited” 
refers to its lateral resolution). Scale bar corresponds to 1 µm. The plasma membrane 
border outline on this panel was generated using the Threshold and Wand (tracing) 
tool functions of Image J (see figure 4.15). The fragment, highlighted as a square on 
the left upper panel, was then imaged using dSTORM and the result is shown on the 
central panel. Scale bar corresponds to 1 µm. Right panel (Merge) shows co-
positioning of the two images. Expanded fragments on the middle and bottom panels 
are taken from the peripheral regions highlighted on the Merge image by arrowheads 
(upper arrowhead corresponds to the middle set of images).  
Note the improvement of resolution in comparison with diffraction-limited images (left 















Figure 4.14b. ER-PM junctions (ER&PM linkers) in migrating pancreatic ductal 
adenocarcinoma cells imaged at super-resolution level.  
Expanded fragments taken from the peripheral regions of other super-resolution 
images (not shown). Note the improvement of resolution in comparison with 
diffraction limited images (left panels). Lateral dSTORM resolution in these 














Figure 4.15. A procedure for determining the outline of the leading edge and 
superimposing it on image of ER-PM junctions. 
This image set shows how the plasma membrane border outline on the diffraction-
limited image of ER-PM junctions (figure 4.14a) was created by using the Threshold 
and Wand (tracing) tool functions in Image J software. Briefly, image of PM linker was 
adjusted to threshold points until the plasma membrane border can be distinguished 
(top right) and then the now-distinguishable border line was mapped using the Wand 
tracing tool (bottom right). Finally the mapped outline was super-imposed onto the ER 
linker image using ROI manager add tool in Image J (bottom left). Scale bars 





In this chapter I show that PANC-1 cells undergo dramatic morphological changes 
from apical-basal polarity to front-rear polarity upon EMT observed using light 
microscopy approach. The morphological changes we observed are phenotypic 
characteristic hallmarks of the EMT switch (Hanahan & Weinberg, 2011; Lamouille et 
al., 2014). EMT is integral to a number of physiological processes including 
embryogenesis, organ development, and wound healing and tissue regeneration 
after damage (Lamouille et al., 2014). Moreover, cancer cells have adopted the 
physiological process of EMT to enable the development of motile and invasive 
signatures in order to aid their metastatic nature, survival and progression. Reverse 
EMT also known as mesenchymal-epithelial transition (MET) cooperates with EMT 
to facilitate the formation of cancer metastases at distant sites from primary tumour 
sites (Thiery et al., 2009; Hanahan & Weinberg, 2011; Chang et al., 2012). A number 
of studies have reported the importance of EMT in cervical (Ricono et al., 2009), 
ovarian (Ahmed et al., 2006) and liver (Fuchs et al., 2008) cancers as well as in the 
progression of pancreatic cancer (Li et al., 2009; Cano et al., 2010; Hotz et al., 2011; 
Wang et al., 2011; Chang et al., 2012). 
The formation of new cellular front-rear polarity is characterised by the formation of 
broad, ruffling lamellipodia, and filopodia-like protrusions at the front leading edge 
while at the cell rear is the trailing tail. We observed that the newly formed front-rear 
polarity in individual migrating PANC-1 cells upon EMT is accompanied by the 
redistribution of ER Ca2+ release channels IP3Rs – specifically of IP3R1 and IP3R2 
but not IP3R3. IP3R1 and IP3R2 underwent redistribution from intercellular junctions 




front leading edge of individual migrating PANC-1 cells upon EMT (Figures 4.2 and 
4.5). In addition to the observed redistribution of IP3Rs, the distribution of SOCE-
competent ER-PM junctions was monitored during EMT switch. Pre-existing ER-PM 
junctions as revealed by ER-PM linkers and the sum-total of pre-existing and newly 
formed ER-PM junctions as revealed by STIM1 puncta formation following ER Ca2+ 
store depletion also underwent redistribution from near-intercellular junctions to the 
leading edge of individual migrating PANC-1 cells. A recent study from our group 
also showed that SOCE-competent ER-PM junctions prominently decorate the 
leading edge of migrating PANC-1 cells, and ER density was not increased but 
instead decreased towards the cell periphery (Dingsdale et al., 2013). Upon EMT 
and disconnection of individual cells from their neighbours, E-cadherin staining was 
not detectable in individual migrating PANC-1 cells with mesenchymal phenotype (N 
= ≥3, data not shown), supporting the loss of epithelial phenotype. This is consistent 
with previously reported findings of the down-regulation of ‘epithelial’ genes during 
EMT switch and thus epithelial intercellular junction complexes (tight junction 
components, adherens junction components and desmosomes components) are 
destabilised, deconstructed, trafficked away from the intercellular junctions and 
perhaps degraded (Chang et al., 2012; Lamouille et al., 2014). Particularly, Chang 
and colleagues showed that the cellular depletion of EFGR in PANC-1 cells 
suppressed EMT and to a significant extent reversed EMT (MET) by restoring apical-
basal polarity and intercellular junctions as the epithelial phenotype marker E-
cadherin was augmented. Concomitantly, the mesenchymal markers including N-
cadherin, vimentin and fibronectin, and transcription factors SNAIL and SLUG were 




have reported that EGF and EGFR induce EMT in cervical (Ricono et al., 2009), 
ovarian (Ahmed et al., 2006) and liver (Fuchs et al., 2008) cancers. 
It is widely reported and generally accepted that dramatic morphological changes 
from apical-basal to front-rear polarity observed at the cellular level upon EMT is also 
accompanied by remodelling of the actin cytoskeleton and other intracellular proteins 
and structures at the subcellular level (Nelson, 2009; Chang et al., 2012; Lamouille 
et al., 2014). This is in line with the observed redistribution of IP3R1 and IP3R2 during 
EMT switch. However, IP3R3 failed to undergo redistribution and was retained in the 
perinuclear region of individual migrating PANC-1 cells. The distribution of ER 
network in polarised connected PANC-1 cells (epithelial phenotype) and in individual 
migrating PANC-1 cells (mesenchymal phenotype) was determined (compare Figure 
4.10 from this chapter to Figure 3.21 from chapter 3) and surprisingly was similar i.e. 
the density of ER network is enriched in the perinuclear region and reduced towards 
the cell periphery in both cases. This suggests that bulk ER network is resistant to 
remodelling in PANC-1 cells upon EMT, and that IP3R3 are not dynamic but rather 
somehow immobilised in the perinuclear bulk ER region where they are resistant to 
redistribution following EMT. On the other hand, perinuclear-localised IP3R2 as well 
as intercellular junctional-localised IP3R1 in connected PANC-1 cells underwent 
redistributions to concentrate at the leading edge of individual migrating PANC-1 
cells, suggesting that IP3R1 and IP3R2 isoforms are significantly more mobile than 
IP3R3s, and hence can be translocated to specialised regions (possibly that of 
cortical ER) in close proximity to the leading edge plasma membrane upon EMT 
through a currently unknown mechanism. Isoforms of IP3R have been reported to 
exhibit different mobility within the ER membrane (Pantazaka & Taylor, 2011). A 




mediated via the polarity complexes (Crumbs, PAR and Scribble), as they have also 
been reported to redistribute from the intercellular junctional area to the leading edge 
of migrating cells following EMT (Nelson, 2009; Lamouille et al., 2014). It is also 
possible that phospholipids such as phosphatidylinositol 4,5-bisphosphate (PIP2) and 
phosphatidylinositol 3,4,5-bisphosphate (PIP3), which have been shown to 
redistribute during EMT (Saarikangas et al., 2010) could play a part in the 
redistribution of IP3R1 upon EMT. 
In view of the highly polarised distribution of IP3R1 at intercellular junctions and at 
the leading edge in connected and migrating PANC-1 cells, respectively, I next 
examined the subcellular spatial relationship of IP3R1 Ca
2+ release platforms and 
SOCE-competent ER-PM junctions in individual migrating PANC-1 cells. 
Interestingly, it was observed that Ca2+ release platforms (IP3R1) and Ca
2+ 
replenishing platforms (ER-PM junctions) were both localised at the leading edge of 
migrating PANC-1 cells, where the ER-PM junctions were positioned just behind the 
IP3R1 positive region at the leading edge. The positional relationship between Ca
2+ 
release and Ca2+ replenishing signalling complexes has been demonstrated in non-
motile polarised pancreatic acinar cell clusters, which showed that apically-localised 
IP3Rs Ca
2+ release channels are spatially segregated from the basolaterally-
positioned SOCE/ER-PM junctions (Lur et al., 2009). This is the first study to 
demonstrate the spatial relationship of Ca2+ release and Ca2+ replenishing signalling 
complexes at the leading edge of migrating cells, suggesting that a stratified 
distribution of Ca2+ signalling complexes might be a strategy employed by both 
normal and cancerous cells of the exocrine pancreas to achieve and maintain 
effective co-ordination of Ca2+ signals in proximity to migratory apparatus. The 




edge of individual migrating PANC-1 cells using dSTORM super-resolution imaging 
technique (see methods section), which has considerably improved axial and lateral 
resolution of ~60 nm in comparison to the conventional confocal microscope (~300 
nm). dSTORM imaging also showed that both IP3R1 and ER-PM junctions can be 
observed in the immediate proximity to the ventral membrane area of the leading 
edge in migrating PANC-1 cells (in other words, the region of the membrane involved 
in forming contacts with and sliding along the substratum). A number of recent 
studies have reported the importance of Ca2+ signalling for cell migration (Wei et al., 
2009; Yang et al., 2009; Middelbeek et al., 2012; Schafer et al., 2012; Tsai & Meyer, 
2012; Tsai et al., 2014). Ca2+ responses have been shown to both potentiate (Wei et 
al., 2009; Yang et al., 2009; Middelbeek et al., 2012; Schafer et al., 2012; Tsai et al., 
2014) and suppress migration (Tsai et al., 2014), depending on cell type and 
extracellular environment. Considering the observed prominent stratified localisation 
of IP3Rs and STIM1-competent ER-PM junctions at the leading edge of migrating 
PANC-1 cells, I next tested the importance of IP3Rs and SOCE for the migration of 





Chapter 5: IP3Rs and ER-PM junctions regulate pancreatic ductal 












Chapter 5: IP3Rs and ER-PM junctions regulate pancreatic ductal 
adenocarcinoma cell migration 
5.1 Cell migration and its regulation by IP3Rs and SOCE   
Cell migration is a highly co-ordinated cellular behaviour which is important for 
numerous physiological processes including embryogenesis, organ development, 
immune surveillance, wound healing and tissue regeneration (Valeyev et al., 2006; 
Ridley, 2011; Roussos et al., 2011; Lamouille et al., 2014). The process of cell 
migration is also essential for the development, spreading and progression of cancer 
(Hanahan & Weinberg, 2000, 2011; Roussos et al., 2011; Lamouille et al., 2014). 
Ca2+ has been documented to be a critical regulator of cell migration in many cell 
types (Brundage et al., 1991; Berridge et al., 1998; Pettit & Fay, 1998; Berridge et 
al., 2000; Wei et al., 2009; Yang et al., 2009; Middelbeek et al., 2012; Tsai et al., 
2014). Ca2+ signals produced by both IP3R-mediated Ca
2+ release from intracellular 
stores and Ca2+ influx across the PM via STIM1-gated Orai1 channels and transient 
receptor potential (TRP, specifically TRPM7) channels have all been shown to be 
critical for migration in a number of cell types (Wei et al., 2009; Yang et al., 2009; 
Middelbeek et al., 2012; Schafer et al., 2012; Tsai & Meyer, 2012; Tsai et al., 2014). 
In this part of the study, we investigated the significance of IP3Rs and SOCE for the 
migration of PANC-1 cells using multiple cell migration assays, and studied how 
these Ca2+ signalling complexes regulate the migratory apparatus in order to control 






5.2 Inhibition of IP3-induced Ca
2+ release and store-operated Ca2+ 
entry (SOCE) suppresses PANC-1 cell migration 
After characterising a remarkable redistribution and positioning of IP3Rs and STIM1-
competent ER-PM junctions at the leading edge of migrating PANC-1 cells, and 
considering their subcellular localisation I next sought to determine whether or not 
IP3Rs and ER-PM junctions are essential for the migration of PDAC cells. Employing 
Xestospongin-B (selective inhibitor of IP3Rs (Jaimovich et al., 2005); see Figure 3.6) 
and GSK-7975A (selective inhibitor of store-operated Ca2+ channels Orai1 and Orai3 
(Derler et al., 2013)), and using Boyden chamber migration assay with symmetric 
Foetal Bovine Serum (FBS) distribution (1% (v/v) FBS in both upper and lower 
chambers), it was found that both Xestospongin-B and GSK-7975A significantly 
inhibit the migration of PANC-1 cells (Figure 5.1). Using asymmetric FBS distribution 
(0% (v/v) FBS in upper chamber and 5% (v/v) FBS in lower chamber) as a model of 
chemotactic migration, it was observed that both Xestospongin-B and GSK-7975A 
significantly inhibit the migration of PANC-1 cells (Figure 5.2). Note that inhibitory 
effects of Xestospongin-B and GSK-7975A on the migration of PANC-1 cells were 
stronger in experiments with asymmetric FBS distribution (Figure 5.2 compared to 
Figure 5.1). In the chemotactic condition, Xestospongin-B inhibited migration by 74 ± 
9% (Mean ± SEM), and GSK-7975A inhibited migration by 84 ± 3%. Furthermore, 
both Xestospongin-B and GSK-7975A also inhibited PANC-1 cell migration as 
measured by wound-healing assay (Figure 5.3). A zero FBS condition (0% FBS in 
both chambers) was employed for comparison, and this effectively inhibits PANC-1 
cell migration (Figures 5.1 – 5.3). Moreover, neither Xestospongin-B nor GSK-7975A 




Our experimental data showing strong inhibition of migration by Xestospongin-B and 
GSK-7975A suggest that the striking accumulation of IP3Rs and STIM1/SOCE-
competent ER-PM junctions at the leading edge of PDAC cells has a clear function, 







Figure 5.1. Inhibition of IP3Rs and SOCE suppress pancreatic ductal 
adenocarcinoma cell migration. 
Xestospongin-B and GSK-7975A suppress migration of PANC-1 cells.  PANC-1 cells 
were subjected to symmetric (1% FBS in both chambers) Boyden chamber migration 
assay for 6 hours at 37°C in the absence (Control) or presence of the inhibitors. No 
FBS condition (0% FBS in both chambers) was employed for comparison (this 
effectively inhibits cell migration). The effects of the inhibitor-treated groups were 
obtained as a function of normalisation to the control group; normalisation was 
conducted for each individual experiment. Mean ± SEM was obtained from at least 3 
independent experiments. In all cases the number of migrated cells in the presence of 
an inhibitor was statistically different from that in the control condition. 




































































Figure 5.2. Inhibition of IP3Rs and SOCE suppress pancreatic ductal 
adenocarcinoma cell migration. 
Xestospongin-B and GSK-7975A suppress migration of PANC-1 cells. PANC-1 cells 
were subjected to asymmetric (0% FBS in upper chamber and 5% FBS in lower 
chamber) Boyden chamber migration assay for 6 hours at 37°C in the absence 
(Control) or presence of the inhibitors. No FBS condition (0% FBS in both chambers) 
was employed for comparison (this effectively inhibits cell migration). The effects of 
the inhibitor-treated groups were obtained as a function of normalisation to the control 
group; normalisation was conducted for each individual experiment. Mean ± SEM 
was obtained from at least 3 independent experiments. In all cases the number of 







Figure 5.3. Inhibition of IP3Rs and SOCE suppress pancreatic ductal 
adenocarcinoma cell migration measured using wound-healing assay. 
Xestospongin-B and GSK-7975A suppress migration of PANC-1 cells. PANC-1 cells 
seeded on uncoated glass-bottom dishes with ibidi cell culture inserts were subjected 
to a wound-healing assay for 18 hours at 37°C in the absence (Control) or presence 
of the inhibitors. No FBS condition (0% FBS) was employed for comparison (this 
effectively inhibits cell migration). Wound area was imaged at time 0 and 18 hours.  
Mean ± SEM was obtained from at least 3 independent experiments. In all cases the 
number of migrated cells in the presence of an inhibitor was statistically different from 
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Figure 5.4. Xestospongin-B and GSK-7975A did not induce substantial cellular 
toxicity in pancreatic ductal adenocarcinoma cells.  
PANC-1 cells were incubated without / with 50 µM Xestospongin-B or 30 µM GSK-
7975A for 6 hours at 37°C / 5% CO
2
 to mimic the condition employed in Boyden 
chamber and wound-healing migration assays. Post-incubation, PANC-1 cells were 
co-incubated with Hoechst-33342 (cellular nuclei marker for total cell count) and 
Sytox orange (red, cellular nuclei marker for cells with compromised plasma 
membrane i.e. dead cells) for 20 min at 37°C / 5% CO
2
 prior to cell imaging. Green 
column indicates live cells and the number of live cells were calculated by subtracting 
Sytox orange-stained positive cells (red, dead cells) from Hoechst-stained positive 
cells (total cell count). Red column indicates dead cells. Mean ± SEM was obtained 
from at least 3 independent experiments. In all cases the number of live/dead cells in 














Figure 5.5. Xestospongin B and GSK-7975A did not induce cellular toxicity in 
pancreatic ductal adenocarcinoma cells. 
Representative images showing Hoechst 33342- and Sytox orange-stained cells in 
the presence or absence of the inhibitors of specific Ca
2+
 signalling complexes 




5.3 Cellular depletion of IP3Rs suppresses PANC-1 cell migration 
After using the specific pharmacological inhibitor Xestospongin-B to demonstrate 
that IP3Rs are important for the migration of PDAC cells, it was necessary to 
determine whether all 3 isoforms or a particular isoform of IP3R is responsible for 
providing the Ca2+ signals required for PDAC cell migration. To address this 
question, the effect of siRNA knockdown of each isoform of IP3R on the chemotactic 
model of cell migration was examined. Cellular depletion of IP3R1 significantly 
inhibited cell migration by 58 ± 6% (Figure 5.6, upper panel). Similar significant 
inhibitory effect on cell migration (by 36 ± 1%) was observed after siRNA knockdown 
of IP3R2 (Figure 5.7, upper panel), although the magnitude of inhibition observed 
after IP3R2 knockdown was less than that observed after IP3R1 knockdown. siRNA 
knockdown of IP3R3 had no effect on cell migration (Figure 5.8, upper panel). To 
confirm the cellular depletion of each isoform of IP3R, the extent of knockdown of 
each isoform of IP3R was analysed by Western blotting. Western blot profiles 
showed clear evidence for IP3R1 (Figure 5.6, lower panels), IP3R2 (Figure 5.7, lower 
panels) and IP3R3 (Figure 5.8, lower panels) knockdown. 
These experimental observations indicate that the cellular depletion of IP3R1 and 
IP3R2 suppressed the migration of PDAC cells, and that IP3R1 and IP3R2 but not 
IP3R3 are the isoforms responsible for providing Ca
2+ signals required for PDAC cell 
migration. This finding is in agreement with the previous observation of the formation 
of new cellular (front-rear) polarity after EMT, which was accompanied by the 
redistribution of IP3R1 and IP3R2 (but not IP3R3) from cell-cell contacts and the 
perinuclear region in connected PDAC cells, respectively, to preferential localisation 






Figure 5.6. Cellular depletion of IP3R1 suppresses pancreatic ductal 
adenocarcinoma cell migration. 
siRNA knockdown of IP
3
R1 inhibits the chemotactic migration of pancreatic ductal 
adenocarcinoma cells. PANC-1 cells were subjected to chemotactic (asymmetric; 0% 
FBS in upper chamber and 5% FBS in lower chamber) Boyden chamber migration 
assay for 6 hours at 37°C / 5% CO
2
, 72 hours post-transfection with IP
3
R1 siRNA (R1 
siRNA) or non-targeting siRNA (NC siRNA) oligomer sequences. The effect of the 
targeting siRNA group was obtained as a function of normalisation to the non-
targeting control group. Mean ± SEM was obtained from at least 3 independent 
experiments. 
Western blot profile shows the evidence for IP
3
R1 siRNA knockdown (lower panel). 
IP
3
R1 and actin levels were quantified using Image J densitometry tool. The amount 
of IP
3
R1 was obtained as a function of normalisation to the amount of actin protein. 
Actin blot was used as a loading control. Mean ± SEM was obtained from at least 3 
independent experiments. Unpaired t-test with a two-tailed distribution and unequal 
variance was applied. In all cases, the number of migrated cells and the amount of 
IP
3
R1 protein after IP
3
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Figure 5.7. Cellular depletion of IP3R2 suppresses pancreatic ductal 
adenocarcinoma cell migration. 
siRNA knockdown of IP
3
R2 inhibits the chemotactic migration of pancreatic ductal 
adenocarcinoma cells. PANC-1 cells were subjected to chemotactic (asymmetric; 0% 
FBS in upper chamber and 5% FBS in lower chamber) Boyden chamber migration 
assay for 6 hours at 37°C / 5% CO
2
, 72 hours post-transfection with IP
3
R2 siRNA (R2 
siRNA) or non-targeting siRNA (NC siRNA) oligomer sequences. The effect of the 
targeting siRNA group was obtained as a function of normalisation to the non-
targeting control group. Mean ± SEM was obtained from at least 3 independent 
experiments. 
Western blot profile shows the evidence for IP
3
R2 siRNA knockdown (lower panel). 
IP
3
R2 and actin levels were quantified using Image J densitometry tool. The amount 
of IP
3
R2 was obtained as a function of normalisation to the amount of actin protein. 
Actin blot was used as a loading control. Mean ± SEM was obtained from at least 3 
independent experiments. Unpaired t-test with a two-tailed distribution and unequal 
variance was applied. In all cases, the number of migrated cells and the amount of 
IP
3
R2 protein after IP
3












































































Figure 5.8. Cellular depletion of IP3R3 does not suppress pancreatic ductal 
adenocarcinoma cell migration. 
siRNA knockdown of IP
3
R3 fails to inhibit the chemotactic migration of pancreatic 
ductal adenocarcinoma cells. PANC-1 cells were subjected to chemotactic 
(asymmetric; 0% FBS in upper chamber and 5% FBS in lower chamber) Boyden 
chamber migration assay for 6 hours at 37°C / 5% CO
2
, 72 hours post-transfection 
with IP
3
R3 siRNA (R3 siRNA) or non-targeting siRNA (NC siRNA) oligomer 
sequences. The effect of the targeting siRNA group was obtained as a function of 
normalisation to the non-targeting control group. Mean ± SEM was obtained from at 
least 3 independent experiments. 
Western blot profile shows the evidence for IP
3
R3 siRNA knockdown (lower panel). 
IP
3
R3 and actin levels were quantified using Image J densitometry tool. The amount 
of IP
3
R3 was obtained as a function of normalisation to the amount of actin protein. 
Actin blot was used as a loading control. Mean ± SEM was obtained from at least 3 
independent experiments. Unpaired t-test with a two-tailed distribution and unequal 
variance was applied. The amount of IP
3
R3 protein after IP
3
R3 knockdown was 
statistically different from that in the control condition but the number of migrated cells 








































































5.4 Cellular depletion of STIM1 suppresses PANC-1 cell migration 
After applying the pharmacological inhibitor GSK-7975A to demonstrate that store 
operated Ca2+ entry channels are important for the migration of PDAC cells, I further 
examined the effect of STIM1 depletion on the chemotactic model of cell migration. 
Briefly, SOCE is a Ca2+ influx mechanism triggered by ER Ca2+ store depletion, 
which involves oligomerisation of STIM1 (an EF-hand containing protein that serves 
as the ER Ca2+ sensor) and subsequent translocation of STIM1 oligomers to ER-PM 
junctions where they interact with and elicit opening of PM Orai-type Ca2+ channels 
(Liou et al., 2005; Roos et al., 2005; Feske et al., 2006; Wu et al., 2006; Park et al., 
2009). Following the siRNA knockdown of STIM1 proteins (primary activator of Orai 
channels), PANC-1 cell migration was significantly inhibited (Figure 5.9, upper 
panel). Cellular depletion of STIM1 was confirmed by Western blotting (Figure 5.19, 
lower panels).  
This experimental finding shows that cellular depletion of STIM1 suppressed the 
migration of PDAC cells, and that STIM1-gated Orai1-mediated store operated Ca2+ 







Figure 5.9. Cellular depletion of STIM1 suppresses pancreatic ductal 
adenocarcinoma cell migration. 
siRNA knockdown of STIM1 modestly inhibits the chemotactic migration of pancreatic 
ductal adenocarcinoma cells. PANC-1 cells were subjected to chemotactic 
(asymmetric; 0% FBS in upper chamber and 5% FBS in lower chamber) Boyden 
chamber migration assay for 6 hours at 37°C / 5% CO
2
, 72 hours post-transfection 
with STIM1 siRNA (S1 siRNA) or non-targeting siRNA (NC siRNA) oligomer 
sequences. The effect of the targeting siRNA group was obtained as a function of 
normalisation to the non-targeting control group. Mean ± SEM was obtained from at 
least 3 independent experiments. 
Western blot profile shows the evidence for STIM1 siRNA knockdown (lower panel). 
STIM1 and actin levels were quantified using Image J densitometry tool. The amount 
of STIM1 was obtained as a function of normalisation to the amount of actin protein. 
Actin blot was used as a loading control. Mean ± SEM was obtained from at least 3 
independent experiments. Unpaired t-test with a two-tailed distribution and unequal 
variance was applied. In all cases, the number of migrated cells and the amount of 








































































5.5 IP3R1 co-positions with actin- and phospholipid-rich regions at 
the leading edge of migrating PANC-1 cells 
Ca2+ is heavily buffered in the cytosol of most cell types (Zhou & Neher, 1993; 
Mogami et al., 1999) and therefore the proximity of Ca2+ channels to their 
downstream targets is frequently crucial for the efficiency and specificity of signal 
transduction. This work convincingly establishes that IP3Rs and STIM1-competent 
ER-PM junctions are positioned at the leading edge, and are responsible for 
providing Ca2+ signals that are required for the migration of PDAC cells. I therefore 
extended these analyses to examine the positioning of IP3R1 with the effectors of the 
cellular migration machinery, which includes filamentous actin (F-actin) and 
phosphatidylinositols. The leading edge of migrating cells is characterised by a 
region of polymerised actin known as the actin-rich lamellipodia (Ridley, 2011). 
IP3R1 co-positioned with actin-rich lamellipodia at the leading edge of migrating 
PANC-1 cells (Figure 5.10). In addition, a recent study by our laboratory 
demonstrated the close positioning of Ca2+ signalling complex – STIM1-competent 
ER-PM junctions to actin-rich lamellipodia at the leading edge of migrating PDAC 
cells (Dingsdale et al., 2013). Furthermore, in addition to actin polymerisation, the 
importance of phosphatidylinositol signalling in cell migration has been reported 
(Tsai et al., 2014), and phosphatidylinositol phosphates (specifically (PI(4,5)P2 and 
PI(3,4,5)P3) have been shown to display front-rear polarity during migration (Brzeska 
et al., 2012; Tsai et al., 2014). We found that IP3R1 co-localised with PIP2/PIP3 rich 
regions at the leading edge of migrating PANC-1 cells (Figure 5.11). 
Collectively these experimental findings illustrate a close co-positioning of IP3R1 with 




phosphatidylinositol phosphates (PIP2/PIP3)) at the leading edge of actively migrating 
PDAC cells. This finding also supports the notion of the importance of close 



































Figure 5.10. IP3R1 co-positions with actin-rich lamellipodia at the leading edge 
of migrating pancreatic ductal adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and dual-stained using anti-IP
3
R1 antibody and 
phalloidin conjugated Alexa Fluor 647. Scale bar represents 10 µm. Fluorescence 
profiles (bottom panel) are measured along the line spanning the cell membrane of 
the leading edge regions. Fluorescence intensity shown was normalised to the 





































Figure 5.11. IP3R1 co-localises with PIP2/PIP3 rich regions at the leading edge of 
migrating pancreatic ductal adenocarcinoma cells. 
Polarised PANC-1 cells were fixed and dual-stained using anti-IP
3
R1 and anti-
PIP2/PIP3 antibodies. Scale bar represents 10 µm. Fluorescence profiles (bottom 





5.6 STIM1 / ER-PM junctions localise close to focal adhesions in 
migrating PANC-1 cells  
It was earlier demonstrated that STIM1/SOCE contributes to the provision of Ca2+ 
signals required for the migration of PDAC cells (Figures 5.1-5.3 and 5.9). In addition 
to the formation of actin-rich lamellipodia at the leading edge, cell migration requires 
the formation of focal adhesions (structures responsible for interaction between the 
cell and the extracellular matrix) at the front of migrating cells. These observations 
were therefore extended to analyse the relative positioning of STIM1/SOCE-
competent ER-PM junctions and focal adhesions. To visualise SOCE-competent ER-
PM junctions, PANC-1 cells were transfected with TK-YFP-STIM1 for 24 hours prior 
to treatment with 30 μM CPA for 1 hour at 37°C / 5% CO2. Alternatively, PANC-1 
cells were transfected with both PM-targeted LL-FKBP-mRFP and ER-targeted CFP-
FRB-LL linker constructs (Varnai et al., 2007; Dingsdale et al., 2013) for 24 hours 
before treatment with 100 nM rapamycin for 4-5 min at 37°C / 5% CO2. After 
revealing ER-PM junctions by these methods, cells were fixed and immunostained 
with anti-vinculin specific antibody. ER-PM junctions were revealed by STIM1 puncta 
formation following ER Ca2+ store depletion with CPA or by co-localised ER and PM 
linkers without ER Ca2+ store depletion. The ER-PM junctions can be frequently 
found in close proximity to focal adhesions revealed by vinculin (a key regulatory 
component of focal adhesions) staining (Figures 5.12 and 5.13, see the fragment 
shown on the bottom panel). Furthermore, Dingsdale et al. (2013) showed that the 
majority of focal adhesions are positioned within 0.5 µm of nearest STIM1-competent 



















These data show that STIM1/SOCE-competent ER-PM junctions are strategically 
positioned close to focal adhesions in migrating PDAC cells. The close apposition 
between SOCE-competent ER-PM junctions and focal adhesions should make these 
structures particularly sensitive to Ca2+ signals provided through SOC channels at 
the leading edge of migrating cells and could explain the effect of SOCE on cell 
migration (see sub-chapters 5.2 and 5.4). 
 
Vinculin MergeSTIM1 Zoom
Figure 5.12. Relative positioning of STIM1 puncta and focal adhesions in 
migrating pancreatic ductal adenocarcinoma cells. 
STIM1 puncta are in close proximity to focal adhesions in migrating PANC-1 cells. 
Polarised PANC-1 cells transfected with TK-YFP-STIM1 were fixed after treatment 
with CPA, and immunostained using anti-vinculin antibody (to visualise focal 
adhesions). Scale bar represents 10 µm. Zoom image (on the right) shows the 






ER & PM Linkers Vinculin Merge
Figure 5.13. Relative positioning of ER-PM junctions (ER&PM linkers) and focal 
adhesions in migrating pancreatic ductal adenocarcinoma cells. 
ER-PM junctions are in close proximity to focal adhesions in migrating PANC-1 cells. 
Polarised PANC-1 cells co-transfected with both PM-targeted FBKP-LL-mRFP and 
ER-FRB-LL-CFP linker constructs were fixed after treatment with 100 nM rapamycin, 
and immunostained using anti-vinculin antibody (to visualise focal adhesions). Scale 
bar represents 10 µm. Bottom panel shows the fragment outlined by the rectangle in 




5.7 IP3R1 encompass focal adhesions and controls focal adhesion 
remodelling in migrating PANC-1 cells 
Using Xestospongin-B or siRNA knockdown to inhibit/deplete IP3R1 and IP3R2 
isoforms, I have demonstrated that IP3Rs are important contributors to the provision 
of the Ca2+ signals required for the migration of PDAC cells. In addition to 
characterising the close co-positioning of IP3R1 with actin-rich lamellipodia at the 
leading edge of migrating cells, it was logical to characterise the relative positioning 
of IP3R1 with focal adhesions – another key effector of the migration machinery. 
Dual immunostaining of focal adhesions (using antibody against vinculin, a key 
regulatory component of focal adhesions) and IP3R1 revealed remarkable relative 
localisation of the adhesions and the receptors. As expected, focal adhesions were 
preferentially localised close to the front of the migrating cells; the front leading edge 
was also enriched with IP3R1 (Figures 5.14 and 5.15). Importantly, focal adhesions 
were not co-localised but were instead closely surrounded by the receptors forming 
‘potholes’ on the background of IP3R1 immunostaining (see the fragments shown on 
the bottom panel of Figure 5.14 and the associated fluorescence profile). The 
preferential positioning of focal adhesions and IP3R1 as well as ‘potholes’ were 
observed in the smooth-shaped lamellipodia regions of the leading edge (Figure 5.14 
and the B row of Figure 5.15 with the associated fluorescence profile) as well as in 
spiky, filopodia-like protrusions at the leading edge (Figure 5.15 and specifically the 







Figure 5.14. IP3R1 encompass focal adhesions in migrating pancreatic ductal 
adenocarcinoma cells. 
Non-transfected PANC-1 cells were fixed and dual-stained with anti-IP
3
R1 and anti-
vinculin antibodies. Scale bar represents 10 µm.  
IP
3
R1 encompass focal adhesions in migrating pancreatic ductal adenocarcinoma 
cells with a smooth-like leading edge. An expanded fragment of the cell is shown on 
the middle panels and arrowheads indicate focal adhesions encompassed by IP
3
R1. 
Fluorescence profiles (bottom panel) were measured along the line (shown on the top 
left and top central images) spanning the cell membrane of the leading edge and 
crossing a focal adhesion (specifically the lowest of 3 focal adhesions indicated by 











































Figure 5.15. IP3R1 encompass focal adhesions in migrating pancreatic ductal 
adenocarcinoma cells. 
(A) This figure illustrates the relationship between IP
3
R1 and focal adhesions in a cell 
with a complex leading edge composed of smooth (lamellipodia-like) regions and 
some spiky protrusions. Scale bar represents 10 µm. (B) These panels and their 
associated fluorescence profiles (shown on the bottom left panel of row D) represent 
an expanded fragment of a smooth-like region (similar to figure 5.14). (C) These 
panels represent a spiky protrusion with its associated fluorescence profiles (shown 
on the bottom right panel of row D). In both cases the focal adhesions (indicated by 
arrowheads) are surrounded by IP
3
R1. The associated fluorescence profiles were 
measured across the lines shown on the upper panels (A); the focal adhesions 
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The intimate spatial relationship between focal adhesions and IP3R1 concentrated in 
this region should make these structures particularly sensitive to Ca2+ signals 
generated by IP3Rs at the leading edge of migrating cells. Thus, it was of interest to 
further examine the sensitivity of focal adhesions to Ca2+ signals generated by IP3Rs 
in PANC-1 cells. To address this, UV-photoactivatable and membrane permeant IP3 
(caged IP3) was utilised. In these experiments PANC-1 cells expressing 
simultaneously mCherry-labelled paxillin (paxillin-mCherry) and paxillin labelled with 
the Ca2+ sensor GCaMP5 (paxillin-GCaMP5) were utilised. Paxillin was used in 
these experiments because it is an important regulatory component of focal 
adhesions (Deakin & Turner, 2008). Uncaging of IP3 induced rapid accumulation of 
paxillin in focal adhesions and the loss of paxillin in the cytosol (Figure 5.16). These 
findings highlight the importance of IP3Rs for focal adhesion remodelling – a process 
intimately related to migration (Deakin & Turner, 2008; Kim & Wirtz, 2013). Uncaging 
of IP3 also induced Ca
2+ rises resolvable both in the cytosol and at focal adhesions 
(Figure 5.16A). To convincingly demonstrate that the observed remodelling of focal 
adhesions was due to the Ca2+ signals released through IP3Rs following the 
photorelease of IP3 from its caged precursor (uncaging), PANC-1 cells co-expressing 
paxillin-mCherry and paxillin-GCaMP5 were UV-illuminated in the absence of caged 
IP3. Figure 5.17 shows there were no observable changes in paxillin fluorescence in 
focal adhesions or in the cytosol (i.e. no remodelling of focal adhesions). 
Interestingly, after the photorelease of IP3, the increase in the accumulation of 
paxillin in focal adhesions started approximately 20s after Ca2+ rise in focal 
adhesions (the increase in GCaMP5 fluorescence indicates Ca2+ rise) (Figure 




These experimental findings show that focal adhesions are closely encompassed by 
IP3R1, creating a novel stratified signalling microdomain i.e. potholes in excitable 
medium in which Ca2+ released through IP3Rs affects the remodelling of focal 







Figure 5.16. IP3-induced Ca
2+ 
release mediates remodelling of focal adhesions 
in migrating pancreatic ductal adenocarcinoma cells. 
IP
3
 uncaging induces remodelling of focal adhesions. (A) Upper panels show the 
fluorescence of GCaMP5–labelled paxillin (Pax-GCaMP5) before (left) and after 
(right) uncaging. The increase of GCaMP5 fluorescence indicates Ca
2+
 rise; note the 
prominent fluorescence increase in focal adhesions. Scale bar represents 10 µm. The 
lower panels show the distribution of the fluorescence of mCherry-labelled paxillin 
(Pax-mCh) before (left) and after (right) IP
3
 uncaging. Note the prominent increase of 
fluorescence in focal adhesions induced by the uncaging. (B) The graph shows the 
increase of fluorescence (i.e. Pax-mCh accumulation), recorded from the regions of 
interest containing focal adhesions (shown above the traces and indicated by 
arrowheads on A), and the decrease of the Pax-mCh fluorescence in the cytosol (the 
region of interest for this analysis included a large area of cytosol and did not include 
nucleus, not shown). The images on (B) are fragments of the cell shown on (A). (C) 
This panel shows the fluorescence of both GCaMP5–labelled paxillin (Pax-GCaMP5) 
and mCherry-labelled paxillin (Pax-mCh) before and after IP
3
 uncaging as illustrated 
by the traces, which were recorded from the regions of interest containing focal 
adhesions (shown above the traces and indicated by arrowhead on the top left of A ). 
The images on (C) are fragments of the cell shown on (A). Pax-mCh accumulation in 




releases. The arrows on the 






































































Figure 5.17. UV illumination does not induce significant remodelling of focal 
adhesions in PANC-1 cells. 
(A) Upper panels show the fluorescence of GCaMP5–labelled paxillin (Pax-GCaMP5) 
before (left) and after (right) UV illumination in the absence of caged-IP
3
. Note that 
there is no detectable fluorescence increase in focal adhesions (see 5.16A for 
comparison). The lower panels show the distribution of the fluorescence of mCherry-
labelled paxillin (Pax-mCh) before (left) and after (right) UV illumination in the 
absence of caged-IP
3
. Note that there is no detectable change of fluorescence in 
focal adhesions (see 5.16B for comparison). Scale bars represent 10 µm. (B) The 
graph shows that there is no detectable change of fluorescence in both focal 
adhesions (i.e. Pax-mCh accumulation) and in the cytosol before and after UV 
illumination in the absence of caged-IP
3
. The arrow on the graph indicates the period 
of uncaging. The images on (B) are fragments of the cell shown on (A) (the selected 







































PDAC is a lethal disease characterised by disseminated metastasis at diagnosis, 
and hence is accompanied with strong resistance to chemotherapy and poor 
prognosis with median survival period of less than 12 months (Stathis & Moore, 
2010; Siegel et al., 2013). To comprehensively address the pathophysiology and 
disseminated metastatic nature of PDAC, a better understanding of the processes 
integral to metastasis formation is imperative to aid the design of new and effective 
therapies with little or no off-target consequences. Epithelial-mesenchymal transition 
(EMT), cell adhesion, cell migration and invasion are processes essential for 
metastasis formation (Hanahan & Weinberg, 2011; Chang et al., 2012; Lamouille et 
al., 2014). The importance of Ca2+ signalling has been linked to the aforementioned 
processes relevant to the formation of metastases in other cancer cell types (Wei et 
al., 2009; Yang et al., 2009; Davis et al., 2014); however, our understanding of the 
key participating Ca2+ signalling components in this cancer type is limited. Cell 
migration is a critical step in tumour spreading (Yang et al., 2009), thus, the focus of 
the present study was to identify and characterise the role of Ca2+ signalling 
complexes in the migration of PDAC cells. 
Initial observations detailed a remarkable stratified distribution of Ca2+ signalling 
complexes – IP3Rs and STIM1-competent ER-PM junctions at the leading edge of 
migrating PANC-1 cells. The importance of Ca2+ signalling for cell migration in other 
cancer cell types has been documented (Wei et al., 2009; Yang et al., 2009; 
Middelbeek et al., 2012; Schafer et al., 2012; Tsai & Meyer, 2012; Tsai et al., 2014) 
and led me to examine the importance of the observed Ca2+ signalling complexes in 
the migration of the model PDAC cell line, PANC-1. It was observed that the 




suppressed the migration of PANC-1 cells as measured using both Boyden chamber 
migration assay (with both symmetric and asymmetric (used as a model of 
chemotactic migration) FBS distribution), and wound-healing/scratch migration assay 
(figures 5.1-5.3); indicating that both IP3Rs and SOCE components are functionally 
important for the migration of PANC-1 cells. In support of our finding, Ca2+ responses 
have been shown to potentiate cell migration (Wei et al., 2009; Yang et al., 2009; 
Middelbeek et al., 2012; Schafer et al., 2012; Tsai et al., 2014); however, contrary to 
our observation, Ca2+ responses were also reported to suppress cell migration (Tsai 
et al., 2014).  
A small interference RNA (siRNA) approach was employed to assess specifically the 
contributory role of each isoform of IP3R in the migration of PANC-1 cells. These 
experiments demonstrated that the cellular depletion of IP3R1 and IP3R2 but not 
IP3R3 suppressed PANC-1 cell migration (Figures 5.6-5.8), with IP3R1 knockdown 
producing the greatest inhibitory effect on cell migration. Interestingly, the 
remarkable redistribution of IP3R1 and IP3R2 (but not IP3R3) from cell-cell contacts 
and perinuclear region in connected PANC-1 cells, respectively, to preferential 
localisation at the leading edge region of migrating PANC-1 cells upon the formation 
of new cellular (front-rear) polarity during EMT is consistent with the importance of 
IP3R1- and IP3R2-mediated Ca
2+ release signals in the regulation of PANC-1 cell 
migration. In agreement with the finding that IP3Rs are critical for the migration of 
PANC-1 cells, Cheng and colleagues also showed that IP3R2 (but not IP3R3) is 
important for the migration of lung fibroblasts that lack IP3R1 (Wei et al., 2009). This 
strengthens the evidence for a critical involvement of IP3R-mediated Ca
2+ release 
signals in the control of cell migration. It has been documented that the polarity of 




signals, which are critical for the process of cell migration (Wei et al., 2009; Tsai & 
Meyer, 2012; Dingsdale et al., 2013; Tsai et al., 2014). For example, receptor 
tyrosine kinase (RTK) signalling is polarised in migrating cells exhibiting front-rear 
polarity with high density at the front leading edge. PLC signalling which generates 
IP3 to mediate Ca
2+ release from ER, and DAG, which in turn activates PKCs (PKCβ) 
are also polarised in migrating cells (Tsai et al., 2014). Also a higher frequency of 
local Ca2+ pulses (Ca2+ flickers (high Ca2+ microdomains) occur at the front leading 
edge compared to the rear of migrating cells (Wei et al., 2009). Therefore, It is logical 
for one to speculate that high Ca2+ flicker activity at the front leading edge could be 
attributed to the enrichment of IP3Rs in this region. Taken together, these 
observations suggest that the close proximity of RTK signalling, PLC activation, IP3 
and DAG signalling, Ca2+ flickers, and PKCβ activation in the front of migrating cells 
all function in a concerted fashion to mediate local, rapid and efficient Ca2+ signalling 
in close vicinity of downstream migratory effectors (e.g. focal adhesion complexes) to 
regulate cell migration. 
In addition, the cellular depletion of STIM1 proteins (an activator of the PM Orai Ca2+ 
channels) also suppressed PANC-1 cell migration. Consistent with findings that 
STIM1 positively contributes to the migration of PANC-1 cells, other recent reports 
have also shown that STIM1, a key component of SOCE potentiates the migration of 
other cancer cell types including human breast tumour cells and lung cancer (H1299) 
cells (Yang et al., 2009; Schafer et al., 2012; Tsai et al., 2014). Contrary to the 
observations detailed in the work presented here, Tsai et al. (2014) reported that 
STIM1 suppressed the migration of non-tumourigenic human umbilical vein 
endothelial (HUVECs) cells. Briefly, our and other groups (Wei et al., 2009; Yang et 




signals potentiate cell migration, whereas Meyer and colleagues reported that 
increased intracellular Ca2+ signals suppressed cell migration (Tsai et al., 2014). 
Possible reconciliations with the finding of Tsai et al. (2014) are, firstly, a difference 
in cell types: Human PANC-1 cells, human embryonic lung fibroblasts WI-38 (Wei et 
al., 2009), and MEFs and breast tumour cells (Yang et al., 2009) undergo single cell 
migration mode, whereas HUVEC cells employed by Tsai et al. (2014) undergo 
collective migration (with intact cell-cell adhesion). Finally, the findings of Tsai et al. 
(2014) are somewhat self-contradictory because they reported that inhibition of 
SOCE (decreased cytosolic Ca2+ signals) potentiated migration speed but the 
inhibition of PLC activity, which also decreased cytosolic Ca2+ signals, conversely 
suppressed migration speed of HUVEC cells; without describing the status of 
extracellular matrix (e.g. fibronectin) used in their study. 
The data presented in this thesis chapter demonstrate that both IP3Rs- and SOCE-
mediated Ca2+ signals are critical for the migration of PANC-1 cells; however, the 
subcellular spatial relationship of these Ca2+ signalling complexes and effector 
proteins integral to the migration process has yet to be fully elucidated. Knowing that 
Ca2+ is heavily buffered in the cytosol of most cell types (Zhou & Neher, 1993; 
Mogami et al., 1999), it is therefore often observed that the proximity of Ca2+ 
channels to their downstream targets is essential for the efficiency and fidelity of 
signal transduction. As a result, I addressed the subcellular organisation of these 
Ca2+ signalling complexes in relation to prominent components of the migration 
machinery in migrating PANC-1 cells. The ruffling region of the plasma membrane 
necessary for sustained forward movement of the plasma membrane with/without 
protrusions is termed the front leading edge of migrating cells, which is characterised 




closely co-positioned with actin-rich lamellipodia at the leading edge of migrating 
PANC-1 cells (Figure 5.10). Also, Tepikin and colleagues recently showed that 
STIM1-competent ER-PM junctions were found in close proximity to actin-rich 
lamellipodia in migrating PANC-1 cells (Dingsdale et al., 2013). 
The importance of phospholipid signalling in cell migration has been reported with 
PI(4,5)P2/PI(3,4,5)P3 exhibiting front-rear polarity in migrating cells (Brzeska et al., 
2012; Falke & Ziemba, 2014; Tsai et al., 2014). I have been further able to 
demonstrate that IP3R1 co-localises with PI(4,5)P2/PI(3,4,5)P3 phosphatidylinositol-
rich regions at the leading edge of migrating PANC-1 cells (Figure 5.11). 
Interestingly, this suggests that IP3Rs positioned in the immediate vicinity of plasma 
membrane region known as plasmerosome (Blaustein & Golovina, 2001) are 
potentially coupled to / in close proximity to PI(4,5)P2. As a result, this could provide 
a platform for local, rapid and efficient coupling between PLC activation, PIP2 
hydrolysis, IP3 and DAG synthesis and Ca
2+ signalling. The significance of the 
functional coupling between IP3Rs and PI(4,5)P2 for efficient Ca
2+ signalling has 
been previously described by Lupu et al. (1998). Phosphatidylinositol (particularly 
PI(4,5)P2 and PI(3,4,5)P3) has been reported to be essential for the regulation of 
actin cytoskeleton attachment to the plasma membrane and the dynamics of actin-
lamellipodia (Raucher et al., 2000; Saarikangas et al., 2010; Falke & Ziemba, 2014). 
Specifically PI(4,5)P2 has been shown to co-localise with filamentous actin (F-actin) 
at the leading edge protrusion of migrating cells (Brzeska et al., 2012). Regarding 
the species of phosphatidylinositols with which IP3Rs co-localise; I should note that 
anti-PIP2 antibody used in the present study is not specific for PI(4,5)P2 binding as 
revealed using a lipid strips binding test described by Brzeska et al. (2012). The 




(Brzeska et al., 2012). Nonetheless, since PI(4,5)P2 is the most abundant 
phosphatidylinositol in the plasma membrane (Saarikangas et al., 2010), 
phosphatidylinositol staining by the PIP2 antibody should represent a significant 
amount of PI(4,5)P2 staining.  
Focal adhesions link intracellular cytoskeletal structures with the extracellular matrix 
via integral membrane spanning proteins (Webb et al., 2002). Using vinculin as a 
marker for focal adhesions, it was observed that STIM1-competent ER-PM junctions 
(i.e. SOCE platforms) could be found in close proximity to focal adhesions at the 
leading edge, with the majority of focal adhesions positioned within 0.5 µm of nearest 
STIM1-competent ER-PM junctions in migrating PANC-1 cells (Dingsdale et al., 
2013). Interestingly, IP3R1 remarkably encompassed focal adhesions i.e. by creating 
potholes of excitable local Ca2+ signalling medium that surrounds focal adhesions. 
The role of IP3Rs as the fundamental building block of an excitable medium was 
previously documented in different cell types (Foskett et al., 2007). Recently it has 
become widely accepted that focal adhesion size and turnover is critical for cell 
migration speed (Yang et al., 2009; Kim & Wirtz, 2013) and tumour metastasis (Yang 
et al., 2009).  
Consistent with the findings of the present work, studies in breast cancer tumour 
cells (Yang et al., 2009; Middelbeek et al., 2012) and in other cell types (Schafer et 
al., 2012; Tsai & Meyer, 2012; Tsai et al., 2014) have shown that Ca2+ responses are 
important for cell migration by regulating focal adhesion dynamics and turnover. The 
mechanisms involved in these Ca2+ responses have yet to be fully elucidated. 
Recent reports have linked Ca2+ influx via Ca2+ release activated Ca2+ entry (CRAC) 
– STIM1 and Orai1 components (Yang et al., 2009; Tsai et al., 2014), and via 




Ca2+ channel (SACC)) (Middelbeek et al., 2012) to focal adhesion turnover. Tsai and 
Meyer (2012) and Tsai et al. (2014) also suggested a link between IP3R-mediated 
Ca2+ signals and focal adhesion remodelling but they were unable to provide 
experimental evidence directly connecting IP3R-mediated Ca
2+ signalling to focal 
adhesion remodelling. Therefore the present study sought to demonstrate a 
functional casual link between IP3R-mediated Ca
2+ release and focal adhesion 
remodelling in migrating PANC-1 cells. To address this, plasma membrane permeant 
and UV-photoactivatable IP3, paxillin-mCherry and paxillin-GCaMP5 were utilised. 
Upon the photorelease of IP3 and the subsequent opening of IP3Rs, Ca
2+ rises in 
cytosol and focal adhesions followed by the accumulation of paxillin in focal 
adhesions (Figure 5.16), suggesting that there is a casual relationship between IP3R-
mediated Ca2+ releases and focal adhesion remodelling. Interestingly after the 
photorelease of IP3, a 20s latency period between Ca
2+ releases and resolvable 
paxillin accumulation suggests that there may be additional regulatory steps involved 
in the remodelling of focal adhesions. In good agreement with this data, Meyer and 
colleague also reported a latency period of ~16s between local Ca2+ pulses and focal 
adhesion remodelling (Tsai & Meyer, 2012). Calpain and Rho family of small 
GTPases (mainly RhoA, Rac1 and CDC42) are potential candidate effectors 
downstream of Ca2+ responses which are thought to be involved in mediating focal 
adhesion remodelling and actin-lamellipodia-dependent forward movement (Ridley et 
al., 2003; Yang et al., 2009; Ridley, 2011). Calpain (µ-calpain) is a Ca2+ binding 
protease with five EF hand domains that is activated by elevation in cytosolic Ca2+ 
level and its activity has been reported to regulate focal adhesion disassembly and 
turnover (Valeyev et al., 2006). This is another possible candidate for mediating the 




Collectively, these experimental data provides supporting evidence for the 
involvement of Ca2+ signalling complexes (IP3Rs and SOCE – STIM1 & Orai1 
components) in the regulation of PDAC cell migration. It was next discovered in the 
present work that these critical Ca2+ signalling complexes are localised at the leading 
edge of migrating PDAC cells and are strategically positioned in close proximity to 
prominent migratory machinery components including actin-rich lamellipodia, 
phospholipid-rich microdomains and focal adhesion complexes (vinculin and 
paxillin). Furthermore, it was demonstrated that focal adhesions were closely 
encompassed by IP3Rs at the leading edge i.e. creating potholes in excitable 
medium in which Ca2+ released through IP3Rs could affect the remodelling and 
turnover of focal adhesions, which in turn is critical for the migration of PDAC cells. 
Taken together, I successfully demonstrated that Ca2+ signalling complexes regulate 
focal adhesion turnover in order to control cell adhesion dynamics and forward 
movement of PANC-1 cells. The outcome of the present study suggests that 
interfering with the functional relationship between polarised Ca2+ responses and the 
migratory machinery could be an exciting therapeutic avenue to exploit in order to 











Chapter 6: Concluding Remarks 
6.1 Keynote 
Firstly, the present study has demonstrated that Ca2+ signals (through IP3Rs and 
SOCE) are essential for the migration of pancreatic ductal adenocarcinoma (PDAC, 
specifically PANC-1) cells. The molecular mechanism by which these Ca2+ signalling 
complexes control cell migration is likely to involve the regulation of focal adhesion 
remodelling, which in turn controls cell adhesion dynamics and forward movement of 
PANC-1 cells. 
Secondly, based on our experimental findings which showed that IP3Rs underwent 
redistribution upon EMT and a recent report that documented the model for PDAC 
tumour progression from pancreatic acinar cells (Rooman & Real, 2012), we 
postulate that the differential localisation of IP3Rs could exhibit a binary (‘good’ or 
‘bad’) role depending on the physiological and pathophysiological status of cells. For 
example, in non-cancerous epithelial cells (e.g. acinar cells) IP3Rs could be critical 
for physiological functions including fluid and protein secretion, whereas following 
EMT switch in cancer cells (e.g. PDAC) redistribution of IP3Rs to the leading edge is 
critical for the migration/invasion and formation of metastases. 
6.2 IP3Rs and SOCE during EMT and in cell migration 
This study successfully showed that endogenously expressed isoforms of IP3R 
exhibit differential subcellular localisation in clusters and monolayers of PANC-1 
cells. Specifically, IP3R1 was localised at intercellular contacts, whereas both IP3R2 
and IP3R3 were preferentially localised to the perinuclear region. SOCE-competent 




intercellular junctions. The polarised distribution of IP3Rs and SOCE suggests that 
these Ca2+ signalling complexes in the proximity of tight junctions could be important 
for epithelial functions e.g. exocytotic and fluid secretion (Rodriguez-Boulan & 
Nelson, 1989; Ito et al., 1997; Steward et al., 2005; Pandol, 2010; Huang et al., 
2012). 
PDAC is a lethal disease characterised by disseminated metastasis at diagnosis, 
and as a result is accompanied with strong resistance to chemotherapy and poor 
prognosis with median survival period of less than 12 months (Stathis & Moore, 
2010; Siegel et al., 2013). Epithelial-mesenchymal transition (EMT) is an essential 
event in cancer development that is relevant to the process of metastasis (Hanahan 
& Weinberg, 2011; Chang et al., 2012; Lamouille et al., 2014). During EMT, epithelial 
cells disconnect from their neighbours following the down-regulation of epithelial 
signatures and concomitantly the up-regulation of genes that permit trans-
differentiation into motile mesenchymal cells (Lamouille et al., 2014). We observed 
profound morphological changes in PANC-1 cells after EMT and these includes the 
formation of new cellular (front-rear) polarity. This transition was accompanied by the 
redistribution of IP3Rs – specifically IP3R1 and IP3R2 (but not IP3R3) from cell-cell 
contacts and perinuclear region in connected PANC-1 cells, respectively, to the 
leading edge of migrating PANC-1 cells. Interestingly, these observations 
compliment the importance of IP3R1 and IP3R2 for PANC-1 cell migration because 
cellular depletions of IP3R1 and IP3R2 (but not IP3R3) suppressed the migration of 
PANC-1 cells. In addition, SOCE-competent ER-PM junctions also underwent 
profound redistribution to concentrate at the leading edge following EMT. 
Pharmacological inhibition of SOCE and the knockdown of STIM1 (activator of PM 




these findings suggest that the striking accumulation of IP3Rs and STIM1/SOCE-
competent ER-PM junctions at the leading edge of PDAC cells has a clear function, 
which is to provide Ca2+ signals important for the migration of this type of cancer cell. 
It is a widely acknowledged concept that the proximity of Ca2+ signals to their 
downstream targets is frequently crucial for the efficiency and specificity of signal 
transduction as Ca2+ is heavily buffered in the cytosol of most cell types (Zhou & 
Neher, 1993; Mogami et al., 1999). We observed that IP3R1 co-positioned with 
components of the migratory apparatus (actin-rich lamellipodia and 
phosphatidylinositols (PIP2/PIP3)) at the leading edge of migrating PANC-1 cells. 
STIM1/SOCE-competent ER-PM junctions were also found to be strategically 
positioned close to focal adhesions in migrating PANC-1 cells. The close apposition 
between these Ca2+ signalling complexes and migratory apparatus should make 
these structures particularly sensitive to Ca2+ signals provided through IP3Rs and 
SOC channels at the leading edge of migrating cells and could explain the effect of 
IP3R-mediated Ca
2+ release and SOCE on cell migration. Furthermore, we 
demonstrated that focal adhesions were closely encompassed by IP3R1, creating 
potholes in excitable medium in which Ca2+ released through IP3Rs is linked to focal 
adhesion remodelling and turnover, which in turn is necessary for the migration of 
PANC-1 cells. This observation further supports the notion of the importance of close 
proximity of Ca2+ signals to their downstream targets (e.g. migratory apparatus) in 
order to mediate local, efficient and specific signalling. 
Finally, the findings of the present study suggests that interfering with the functional 
relationship between polarised Ca2+ responses and the migratory apparatus could be 
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